Tryp_SPcTrypsin-like serine protease |
![]() |
|---|
| SMART accession number: | SM00020 |
|---|---|
| Description: | Many of these are synthesised as inactive precursor zymogens that are cleaved during limited proteolysis to generate their active forms. A few, however, are active as single chain molecules, and others are inactive due to substitutions of the catalytic triad residues. |
| Interpro abstract (IPR001254): | In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold:
In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding. Proteolytic enzymes that exploit serine in their catalytic activity are ubiquitous, being found in viruses, bacteria and eukaryotes [(PUBMED:7845208)]. They include a wide range of peptidase activity, including exopeptidase, endopeptidase, oligopeptidase and omega-peptidase activity. Many families of serine protease have been identified, these being grouped into clans on the basis of structural similarity and other functional evidence [(PUBMED:7845208)]. Structures are known for members of the clans and the structures indicate that some appear to be totally unrelated, suggesting different evolutionary origins for the serine peptidases [(PUBMED:7845208)]. Not withstanding their different evolutionary origins, there are similarities in the reaction mechanisms of several peptidases. Chymotrypsin, subtilisin and carboxypeptidase C have a catalytic triad of serine, aspartate and histidine in common: serine acts as a nucleophile, aspartate as an electrophile, and histidine as a base [(PUBMED:7845208)]. The geometric orientations of the catalytic residues are similar between families, despite different protein folds [(PUBMED:7845208)]. The linear arrangements of the catalytic residues commonly reflect clan relationships. For example the catalytic triad in the chymotrypsin clan (PA) is ordered HDS, but is ordered DHS in the subtilisin clan (SB) and SDH in the carboxypeptidase clan (SC) [(PUBMED:7845208), (PUBMED:8439290)]. This group of serine proteases belong to the MEROPS peptidase family S1 (chymotrypsin family, clan PA(S))and to peptidase family S6 (Hap serine peptidases). The chymotrypsin family is almost totally confined to animals, although trypsin-like enzymes are found in actinomycetes of the genera Streptomyces and Saccharopolyspora, and in the fungus Fusarium oxysporum [(PUBMED:7845208)]. The enzymes are inherently secreted, being synthesised with a signal peptide that targets them to the secretory pathway. Animal enzymes are either secreted directly, packaged into vesicles for regulated secretion, or are retained in leukocyte granules [(PUBMED:7845208)]. The Hap family, 'Haemophilus adhesion and penetration', are proteins that play a role in the interaction with human epithelial cells. The serine protease activity is localized at the N-terminal domain, whereas the binding domain is in the C-terminal region. |
| GO process: | proteolysis (GO:0006508) |
| GO function: | serine-type endopeptidase activity (GO:0004252) |
| Family alignment: |
There are 12104 Tryp_SPc domains in 11834 proteins in SMART's nrdb database.
Click on the following links for more information.
- Evolution (species in which this domain is found)
-
Click on
to expand nodes. To display all proteins with a Tryp_SPc domain in a specific node, click on it.This tree shows only several representative species. The complete taxonomic breakdown of all proteins with Tryp_SPc domain is also avaliable.
Useful shortcuts: Expand all nodes or Collapse tree
Go to specific node: Anopheles gambiae, Arabidopsis thaliana, Caenorhabditis elegans, Drosophila melanogaster, Homo sapiens, Mus musculus, Rattus norvegicus, Takifugu rubripes - Cellular role (predicted cellular role)
-
Binding / catalysis: Peptidase, Hydrolase
- Disease (disease genes where sequence variants are found in this domain)
-
SwissProt sequences and OMIM curated human diseases associated with missense mutations within the Tryp_SPc domain.
Protein Disease Complement factor B Bb fragment (P00751) (SMART) OMIM:138470: PROPERDIN FACTOR B; BF Coagulation factor IXa heavy chain (P00740) (SMART) OMIM:306900: Hemophilia B ; Warfarin sensitivity Plasmin light chain B (P00747) (SMART) OMIM:173350: Plasminogen Tochigi disease ; Thrombophilia, dysplasminogenemic ; Plasminogen deficiency, types I and II ; Conjunctivitis, ligneous
OMIM:217090:Complement C2a fragment (P06681) (SMART) OMIM:217000: C2 deficiency Thrombin heavy chain (P00734) (SMART) OMIM:176930: Hypoprothrombinemia ; Dysprothrombinemia Coagulation factor XIIa light chain (P00748) (SMART) OMIM:234000: Factor XII deficiency Neutrophil elastase (P08246) (SMART) OMIM:130130: Hematopoiesis, cyclic
OMIM:162800: Neutropenia, congenital
OMIM:202700:Activation peptide (P04070) (SMART) OMIM:176860: Thrombophilia due to protein C deficiency ; Purpura fulminans, neonatal Factor VII heavy chain (P08709) (SMART) OMIM:227500: Factor VII deficiency ; {Myocardial infarction, decreased susceptibility to} Alpha-trypsin chain 2 (P07477) (SMART) OMIM:276000: Trypsinogen deficiency ; Pancreatitis, hereditary
OMIM:167800: - Metabolism (metabolic pathways involving proteins which contain this domain)
-
% proteins involved KEGG pathway ID Description 48.76 map04610 Complement and coagulation cascades 26.15 map04080 Neuroactive ligand-receptor interaction 4.24 map04614 Renin-angiotensin system 3.18 map04810 Regulation of actin cytoskeleton 2.83 map04060 Cytokine-cytokine receptor interaction 2.83 map05211 Renal cell carcinoma 2.83 map04510 Focal adhesion 2.83 map05218 Melanoma 2.12 map04940 Type I diabetes mellitus 2.12 map04650 Natural killer cell mediated cytotoxicity 1.06 map02020 Two-component system - General 1.06 map05215 Prostate cancer This information is based on mapping of SMART genomic protein database to KEGG orthologous groups. Percentage points are related to the number of proteins with Tryp_SPc domain which could be assigned to a KEGG orthologous group, and not all proteins containing Tryp_SPc domain. Please note that proteins can be included in multiple pathways, ie. the numbers above will not always add up to 100%.
- Structure (3D structures containing this domain)
3D Structures of Tryp_SPc domains in PDB
PDB code Main view Title 1a0h 
The x-ray crystal structure of ppack-meizothrombin desf1: kringle/thrombin and carbohydrate/kringle/thrombin interactions and location of the linker chain 1a0j 
Crystal structure of a non-psychrophilic trypsin from a cold-adapted fish species. 1a0l 
Human beta-tryptase: a ring-like tetramer with active sites facing a central pore 1a2c 
Structure of thrombin inhibited by aeruginosin298-a from a blue-green alga 1a3b 
Complex of human alpha-thrombin with the bifunctional boronate inhibitor borolog1 1a3e 
Complex of human alpha-thrombin with the bifunctional boronate inhibitor borolog2 1a46 
Thrombin complexed with hirugen and a beta-strand mimetic inhibitor 1a4w 
Crystal structures of thrombin with thiazole-containing inhibitors: probes of the s1' binding site 1a5g 
Human thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugen 1a5h 
Catalytic domain of human two-chain tissue plasminogen activator complex of a bis-benzamidine 1a5i 
Catalytic domain of vampire bat (desmodus rotundus) saliva plasminogen activator in complex with egr-cmk (glu-gly-arg chloromethyl ketone) 1a61 
Thrombin complexed with a beta-mimetic thiazole-containing inhibitor 1a7s 
Atomic resolution structure of hbp 1ab9 
Crystal structure of bovine gamma-chymotrypsin 1abi 
Structure of the hirulog 3-thrombin complex and nature of the s' subsites of substrates and inhibitors 1abj 
Structure of the hirulog 3-thrombin complex and nature of the s' subsites of substrates and inhibitors 1acb 
Crystal and molecular structure of the bovine alpha- chymotrypsin-eglin c complex at 2.0 angstroms resolution 1ad8 
Complex of thrombin with and inhibitor containing a novel p1 moiety 1ae5 
Human heparin binding protein 1ae8 
Human alpha-thrombin inhibition by eoc-d-phe-pro-azalys-onp 1afe 
Human alpha-thrombin inhibition by cbz-pro-azalys-onp 1afq 
Crystal structure of bovine gamma-chymotrypsin complexed with a synthetic inhibitor 1agj 
Epidermolytic toxin a from staphylococcus aureus 1aht 
Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate) at 1.6 angstroms resolution 1ai8 
Human alpha-thrombin ternary complex with the exosite inhibitor hirugen and active site inhibitor phch2oco-d-dpa- pro-borompg 1aix 
Human alpha-thrombin ternary complex with exosite inhibitor hirugen and active site inhibitor phch2oco-d-dpa-pro- boroval 1aks 
Crystal structure of the first active autolysate form of the porcine alpha trypsin 1amh 
Uncomplexed rat trypsin mutant with asp 189 replaced with ser (d189s) 1an1 
Leech-derived tryptase inhibitor/trypsin complex 1anb 
Anionic trypsin mutant with ser 214 replaced by glu 1anc 
Anionic trypsin mutant with ser 214 replaced by lys 1and 
Anionic trypsin mutant with arg 96 replaced by his 1ane 
Anionic trypsin wild type 1ao5 
Mouse glandular kallikrein-13 (prorenin converting enzyme) 1aq7 
Trypsin with inhibitor aeruginosin 98-b 1au8 
Human cathepsin g 1auj 
Bovine trypsin complexed to meta-cyano-benzylic inhibitor 1aut 
Human activated protein c 1avg 
Thrombin inhibitor from triatoma pallidipennis 1avw 
Complex porcine pancreatic trypsin/soybean trypsin inhibitor, orthorhombic crystal form 1avx 
Complex porcine pancreatic trypsin/soybean trypsin inhibitor, tetragonal crystal form 1awf 
Novel covalent thrombin inhibitor from plant extract 1awh 
Novel covalent thrombin inhibitor from plant extract 1ay6 
Thrombin inhibitor from theonalla, cyclotheanamide-based macrocyclic tripeptide motif 1az8 
Bovine trypsin complexed to bis-phenylamidine inhibitor 1azz 
Fiddler crab collagenase complexed to ecotin 1b0e 
Crystal structure of porcine pancreatic elastase with mdl 101,146 1b0f 
Crystal structure of human neutrophil elastase with mdl 101, 1b5g 
Human thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugen 1b7x 
Structure of human alpha-thrombin y225i mutant bound to d- phe-pro-arg-chloromethylketone 1ba8 
Thrombin inhibitor with a rigid tripeptidyl aldehydes 1bb0 
Thrombin inhibitors with rigid tripeptidyl aldehydes 1bbr 
The structure of residues 7-16 of the a alpha chain of human fibrinogen bound to bovine thrombin at 2.3 angstroms resolution 1bcu 
Alpha-thrombin complexed with hirugen and proflavin 1bda 
Catalytic domain of human single chain tissue plasminogen activator in complex with dansyl-egr-cmk (dansyl-glu-gly- arg chloromethyl ketone) 1bhx 
X-ray structure of the complex of human alpha thrombin with the inhibitor sdz 229-357 1bio 
Human complement factor d in complex with isatoic anhydride inhibitor 1bit 
The crystal structure of anionic salmon trypsin in a second crystal form 1bju 
Beta-trypsin complexed with acpu 1bjv 
Beta-trypsin complexed with appu 1bma 
Benzyl methyl aminimide inhibitor complexed to porcine pancreatic elastase 1bml 
Complex of the catalytic domain of human plasmin and streptokinase 1bmm 
Human alpha-thrombin complexed with [s-(r*,r*)]-4- [(aminoiminomethyl)amino]-n-[[1-[3-hydroxy-2-[(2- naphthalenylsulfonyl)amino]-1-oxopropyl]-2-pyrrolidinyl] methyl]butanamide (bms-186282) 1bmn 
Human alpha-thrombin complexed with [s-(r*,r*)]-1- (aminoiminomethyl)-n-[[1-[n-[(2-naphthalenylsulfonyl)-l- seryl]-pyrrolidinyl]methyl]-3-piperidenecarboxamide (bms- 189090) 1bqy 
Plasminogen activator (tsv-pa) from snake venom 1bra 
Relocating a negative charge in the binding pocket of trypsin 1brb 
Crystal structures of rat anionic trypsin complexed with the protein inhibitors appi and bpti 1brc 
Relocating a negative charge in the binding pocket of trypsin 1bru 
Structure of porcine pancreatic elastase complexed with the elastase inhibitor gr143783 1bth 
Structure of thrombin complexed with bovine pancreatic trypsin inhibitor 1btp 
Unique binding of a novel synthetic inhibitor, n-[3-[4-[4- (amidinophenoxy)-carbonyl]phenyl]-2-methyl-2-propenoyl]-n- allylglycine methanesulfonate to bovine trypsin, revealed by the crystal structure of the complex 1btu 
Porcine pancreatic elastase complexed with (3s, 4r)-1- toluenesulphonyl-3-ethyl-azetidin-2-one-4-carboxylic acid 1btw 
Episelection: novel ki ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface 1btx 
Episelection: novel ki ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface 1bty 
Crystal structure of beta-trypsin in complex with benzamidine 1btz 
Episelection: novel ki ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface 1bui 
Structure of the ternary microplasmin-staphylokinase- microplasmin complex: a proteinase-cofactor-substrate complex in action. 1bzx 
The crystal structure of anionic salmon trypsin in complex with bovine pancreatic trypsin inhibitor 1c1m 
Porcine elastase under xenon pressure (8 bar) 1c1n 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1o 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1p 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1q 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1r 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1s 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1t 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1u 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1v 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c1w 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2d 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2e 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2f 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2g 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2h 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2i 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2j 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2k 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2l 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c2m 
Recruiting zinc to mediate potent, specific inhibition of serine proteases 1c4u 
Selective non electrophilic thrombin inhibitors with cyclohexyl moieties. 1c4v 
Selective non electrophilic thrombin inhibitors with cyclohexyl moieties. 1c4y 
Selective non-electrophilic thrombin inhibitors 1c5l 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5m 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5n 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5o 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5p 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5q 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5r 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5s 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5t 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5u 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5v 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5w 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5x 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5y 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c5z 
Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator 1c9p 
Complex of bdellastasin with porcine trypsin 1c9t 
Complex of bdellastasin with bovine trypsin 1ca0 
Bovine chymotrypsin complexed to appi 1ca8 
Thrombin inhibitors with rigid tripeptidyl aldehydes 1cbw 
Bovine chymotrypsin complexed to bpti 1ce5 
Bovine pancreas beta-trypsin in complex with benzamidine 1cgh 
Human cathepsin g 1cgi 
Three-dimensional structure of the complexes between bovine chymotrypsinogen*a and two recombinant variants of human pancreatic secretory trypsin inhibitor (kazal-type) 1cgj 
Three-dimensional structure of the complexes between bovine chymotrypsinogen*a and two recombinant variants of human pancreatic secretory trypsin inhibitor (kazal-type) 1chg 
Chymotrypsinogen,2.5 angstroms crystal structure, comparison with alpha-chymotrypsin,and implications for zymogen activation 1cho 
Crystal and molecular structures of the complex of alpha- *chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 angstroms resolution 1co7 
R117h mutant rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti) 1cso 
Crystal structure of the omtky3 p1 variant omtky3-ile18i in complex with sgpb 1ct0 
Crystal structure of the omtky3 p1 variant omtky3-ser18i in complex with sgpb 1ct2 
Crystal structure of the omtky3 p1 variant omtky3-thr18i in complex with sgpb 1ct4 
Crystal structure of the omtky3 p1 variant omtky3-val18i in complex with sgpb 1cvw 
Crystal structure of active site-inhibited human coagulation factor viia (des-gla) 1d3d 
Crystal structure of human alpha thrombin in complex with benzothiophene inhibitor 4 1d3p 
Crystal structure of human aplha-thrombin in complex with benzo[b]thiophene inhibitor 3 1d3q 
Crystal structure of human alpha thrombin in complex with benzo[b]thiophene inhibitor 2 1d3t 
Crystal structure of human alpha thrombin in complex with benzo[b]thiophene inhibitor 1 1d4p 
Crystal structure of human alpha thrombin in complex with 5- amidinoindole-4-benzylpiperidine inhibitor 1d6r 
Crystal structure of cancer chemopreventive bowman-birk inhibitor in ternary complex with bovine trypsin at 2.3 a resolution. structural basis of janus-faced serine protease inhibitor specificity 1d6w 
Structure of thrombin complexed with selective non- electrophilic inhibitors having cyclohexyl moieties at p1 1d9i 
Structure of thrombin complexed with selective non- electophilic inhibitors having cyclohexyl moieties at p1 1dan 
Complex of active site inhibited human blood coagulation factor viia with human recombinant soluble tissue factor 1ddj 
Crystal structure of human plasminogen catalytic domain 1de7 
Interaction of factor xiii activation peptide with alpha- thrombin: crystal structure of the enzyme-substrate complex 1dfp 
Factor d inhibited by diisopropyl fluorophosphate 1dic 
Structure of 3,4-dichloroisocoumarin-inhibited factor d 1dit 
Complex of a divalent inhibitor with thrombin 1dle 
Factor b serine protease domain 1dlk 
Crystal structure analysis of delta-chymotrypsin bound to a peptidyl chloromethyl ketone inhibitor 1dm4 
Ser195ala mutant of human thrombin complexed with fibrinopeptide a (7-16) 1doj 
Crystal structure of human alpha-thrombin*rwj-51438 complex at 1.7 a 1dpo 
Structure of rat trypsin 1ds2 
Crystal structure of sgpb:omtky3-coo-leu18i 1dst 
Mutant of factor d with enhanced catalytic activity 1dsu 
Human factor d, complement activating enzyme 1dua 
Crystal structure of exfoliative toxin a 1due 
Crystal structure of exfoliative toxin a s195a mutant 1dva 
Crystal structure of the complex between the peptide exosite inhibitor e-76 and coagulation factor viia 1dwb 
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors 1dwc 
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors 1dwd 
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors 1dwe 
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors 1dx5 
Crystal structure of the thrombin-thrombomodulin complex 1e0f 
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite ii-binding inhibitor 1e34 
Porcine pancreatic elastase complexed with (3s, 4s)n-para- toluenesulphonyl-3-ethyl-4-(carboxylic acid) pyrrolidin-2-one soaked in ph 9 buffer for one minute 1e35 
Porcine pancreatic elastase complexed with (3s, 4s)n-para-toluenesulphonyl -3-ethyl-4-(carboxylic acid)pyrrolidin-2-one soaked in ph 9 buffer for two minutes 1e36 
Porcine pancreatic elastase complexed with (3s, 4s)n-para-nitrobenzenesulphonyl -3-ethyl-4-(carboxylic acid)pyrrolidin-2-one 1e37 
Porcine pancreatic elastase complexed with (3s, 4s)n-para-nitrobenzenesulphonyl -3-ethyl-4-(carboxylic acid)pyrrolidin-2-one soaked in ph 9 buffer for 1 minute 1e38 
Porcine pancreatic elastase complexed with (3s, 4s)n-para-nitrobenzenesulphonyl -3-ethyl-4-(carboxylic acid)pyrrolidin-2-one soaked in ph 9 buffer for 2 minutes 1eai 
Complex of ascaris chymotrpsin/elastase inhibitor with porcine elastase 1eas 
Nonpeptidic inhibitors of human leukocyte elastase. 3. design, synthesis, x-ray crystallographic analysis, and structure-activity relationships for a series of orally active 3-amino-6-phenylpyridin-2-one trifluoromethyl ketones 1eat 
Nonpeptidic inhibitors of human leukocyte elastase. 5. design, synthesis, and x-ray crystallography of a series of orally active 5-amino-pyrimidin-6-one-containing trifluoromethylketones 1eau 
Nonpeptidic inhibitors of human leukocyte elastase. 6. design of a potent, intratracheally active, pyridone-based trifluoromethyl ketone 1eaw 
Crystal structure of the mtsp1 (matriptase)-bpti (aprotinin) complex 1eax 
Crystal structure of mtsp1 (matriptase) 1eb1 
Complex structure of human thrombin with n-methyl-arginine inhibitor 1eb2 
Trypsin inhibitor complex (bpo) 1eja 
Structure of porcine trypsin complexed with bdellastasin, an antistasin-type inhibitor 1ejm 
Crystal structure of the bpti ala16leu mutant in complex with bovine trypsin 1ejn 
Urokinase plasminogen activator b-chain inhibitor complex 1ekb 
The serine protease domain of enteropeptidase bound to inhibitor val-asp-asp-asp-asp-lys-chloromethane 1ela 
Analogous inhibitors of elastase do not always bind analogously 1elb 
Analogous inhibitors of elastase do not always bind analogously 1elc 
Analogous inhibitors of elastase do not always bind analogously 1eld 
Structural analysis of the active site of porcine pancreatic elastase based on the x-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors 1ele 
Structural analysis of the active site of porcine pancreatic elastase based on the x-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors 1elf 
Nature of the inactivation of elastase by n-peptidyl-o- aroyl hydroxylamine as a function of ph 1elg 
Nature of the inactivation of elastase by n-peptidyl-o- aroyl hydroxylamine as a function of ph 1elt 
Structure of native pancreatic elastase from north atlantic salmon at 1.61 angstroms resolution 1elv 
Crystal structure of the catalytic domain of human complement c1s protease 1eoj 
Design of p1' and p3' residues of trivalent thrombin inhibitors and their crystal structures 1eol 
Design of p1' and p3' residues of trivalent thrombin inhibitors and their crystal structures 1ept 
Refined 1.8 angstroms resolution crystal structure of porcine epsilon-trypsin 1eq9 
Crystal structure of fire ant chymotrypsin complexed to pmsf 1esa 
Direct structure observation of an acyl-enzyme intermediate in the hydrolysis of an ester substrate by elastase 1esb 
Direct structure observation of an acyl-enzyme intermediate in the hydrolysis of an ester substrate by elastase 1est 
The atomic structure of crystalline porcine pancreatic elastase at 2.5 angstroms resolution. comparisons with the structure of alpha-chymotrypsin 1etr 
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics 1ets 
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics 1ett 
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics 1euf 
Bovine duodenase(new serine protease), crystal structure 1ex3 
Crystal structure of bovine chymotrypsinogen a (tetragonal) 1exf 
Exfoliative toxin a 1ezq 
Crystal structure of human coagulation factor xa complexed with rpr128515 1ezs 
Crystal structure of ecotin mutant m84r, w67a, g68a, y69a, d70a bound to rat anionic trypsin ii 1ezu 
Ecotin y69f, d70p bound to d102n trypsin 1ezx 
Crystal structure of a serpin:protease complex 1f0r 
Crystal structure of human coagulation factor xa complexed with rpr208815 1f0s 
Crystal structure of human coagulation factor xa complexed with rpr208707 1f0t 
Bovine trypsin complexed with rpr131247 1f0u 
Bovine trypsin complexed with rpr128515 1f2s 
Crystal structure of the complex formed between bovine beta- trypsin and mcti-a, a trypsin inhibitor of squash family at 1.8 a resolution 1f5k 
Urokinase plasminogen activator b-chain-benzamidine complex 1f5l 
Urokinase plasminogen activator b-chain-amiloride complex 1f5r 
Rat trypsinogen mutant complexed with bovine pancreatic trypsin inhibitor 1f7z 
Rat trypsinogen k15a complexed with bovine pancreatic trypsin inhibitor 1f92 
Urokinase plasminogen activator b chain-uki-1d complex 1fak 
Human tissue factor complexed with coagulation factor viia inhibited with a bpti-mutant 1fax 
Coagulation factor xa inhibitor complex 1fdp 
Proenzyme of human complement factor d, recombinant profactor d 1fi8 
Rat granzyme b [n66q] complexed to ecotin [81-84 iepd] 1fiw 
Three-dimensional structure of beta-acrosin from ram spermatozoa 1fiz 
Three dimensional structure of beta-acrosin from boar spermatozoa 1fjs 
Crystal structure of the inhibitor zk-807834 (ci-1031) complexed with factor xa 1fle 
Crystal structure of elafin complexed with porcine pancreatic elastase 1fmg 
Crystal structure of porcine beta trypsin with 0.04% polydocanol 1fn6 
Crystal structure of porcine beta trypsin with 0.1% polydocanol 1fn8 
Fusarium oxysporum trypsin at atomic resolution 1fni 
Crystal structure of porcine beta trypsin with 0.01% polydocanol 1fon 
Crystal structure of bovine procarboxypeptidase a-s6 subunit iii, a highly structured truncated zymogen e 1fpc 
Active site mimetic inhibition of thrombin 1fph 
The interaction of thrombin with fibrinogen: a structural basis for its specificity 1fq3 
Crystal structure of human granzyme b 1fuj 
Pr3 (myeloblastin) 1fv9 
Crystal structure of human microurokinase in complex with 2- amino-5-hydroxy-benzimidazole 1fxy 
Coagulation factor xa-trypsin chimera inhibited with d-phe- pro-arg-chloromethylketone 1fy1 
[r23s,f25e]hbp, a mutant of human heparin binding protein (cap37) 1fy3 
[g175q]hbp, a mutant of human heparin binding protein (cap37) 1fy4 
Fusarium oxysporum trypsin at atomic resolution 1fy5 
Fusarium oxysporum trypsin at atomic resolution 1fy8 
Crystal structure of the deltaile16val17 rat anionic trypsinogen-bpti complex 1fzz 
The crystal structure of the complex of non-peptidic inhibitor ono-6818 and porcine pancreatic elastase. 1g2l 
Factor xa inhibitor complex 1g2m 
Factor xa inhibitor complex 1g30 
Thrombin inhibitor complex 1g32 
Thrombin inhibitor complex 1g36 
Trypsin inhibitor complex 1g37 
Crystal structure of human alpha-thrombin complexed with bch-10556 and exosite-directed peptide 1g3b 
Bovine beta-trypsin bound to meta-amidino schiff base magnesium(ii) chelate 1g3c 
Bovine beta-trypsin bound to para-amidino schiff base iron(iii) chelate 1g3d 
Bovine beta-trypsin bound to meta-amidino schiff base copper (ii) chelate 1g3e 
Bovine beta-trypsin bound to para-amidino schiff-base copper (ii) chelate 1g9i 
Crystal structure of beta-trysin complex in cyclohexane 1gbt 
Structure of an acyl-enzyme intermediate during catalysis: (guanidinobenzoyl) trypsin 1gcd 
Refined crystal structure of "aged" and "non-aged" organophosphoryl conjugates of gamma-chymotrypsin 1gct 
Is gamma-chymotrypsin a tetrapeptide acyl-enzyme adduct of gamma-chymotrypsin? 1gdn 
Fusarium oxysporum trypsin at atomic resolution 1gdq 
Fusarium oxysporum trypsin at atomic resolution 1gdu 
Fusarium oxysporum trypsin at atomic resolution 1gg6 
Crystal stucture of gamma chymotrypsin with n-acetyl- phenylalanine trifluoromethyl ketone bound at the active site 1ggd 
Crystal stucture of gamma chymotrypsin with n-acetyl-leucil- phenylalanine aldehyde bound at the active site 1gha 
A second active site in chymotrypsin? the x-ray crystal structure of n-acetyl-d-tryptophan bound to gamma- chymotrypsin 1ghb 
A second active site in chymotrypsin? the x-ray crystal structure of n-acetyl-d-tryptophan bound to gamma- chymotrypsin 1ghv 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1ghw 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1ghx 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1ghy 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1ghz 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi0 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi1 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi2 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi3 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi4 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi5 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi6 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi7 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi8 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gi9 
A novel serine protease inhibition motif involving a multi- centered short hydrogen bonding network at the active site 1gj4 
Selectivity at s1, h2o displacement, upa, tpa, ser190/ala190 protease, structure-based drug design 1gj5 
Selectivity at s1, h2o displacement, upa, tpa, ser190/ala190 protease, structure-based drug design 1gj6 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gj7 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gj8 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gj9 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gja 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gjb 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gjc 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gjd 
Engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets 1gl0 
Structure of the complex between bovine alpha-chymotrypsin and pmp-d2v, an inhibitor from the insect locusta migratoria 1gl1 
Structure of the complex between bovine alpha-chymotrypsin and pmp-c, an inhibitor from the insect locusta migratoria 1gmc 
The x-ray crystal structure of the tetrahedral intermediate of gamma-chymotrypsin in hexane 1gmd 
X-ray crystal structure of gamma-chymotrypsin in hexane 1gmh 
Refined crystal structure of "aged" and "non-aged" organophosphoryl conjugates of gamma-chymotrypsin 1gpz 
The crystal structure of the zymogen catalytic domain of complement protease c1r 1gvk 
Porcine pancreatic elastase acyl enzyme at 0.95 a resolution 1gvl 
Human prokallikrein 6 (hk6)/ prozyme/ proprotease m/ proneurosin 1gvz 
Prostate specific antigen (psa) from stallion seminal plasma 1gwa 
Triiodide derivative of porcine pancreas elastase 1h1b 
Crystal structure of human neutrophil elastase complexed with an inhibitor (gw475151) 1h4w 
Structure of human trypsin iv (brain trypsin) 1h8d 
X-ray structure of the human alpha-thrombin complex with a tripeptide phosphonate inhibitor. 1h8i 
X-ray crystal structure of human alpha-thrombin with a tripeptide phosphonate inhibitor. 1h9h 
Complex of eeti-ii with porcine trypsin 1h9i 
Complex of eeti-ii mutant with porcine trypsin 1h9l 
Porcine pancreatic elastase complexed with acetyl-val-glu-pro-ile-cooh 1hag 
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin 1hah 
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin 1hai 
The isomorphous structures of prethrombin2, hirugen-and ppack-thrombin: changes accompanying activation and exosite binding to thrombin 1hao 
Complex of human alpha-thrombin with a 15mer oligonucleotide ggttggtgtggttgg (based on nmr model of dna 1hap 
Complex of human alpha-thrombin with a 15mer oligonucleotide ggttggtgtggttgg (based on x-ray model of dna) 1hax 
Snapshots of serine protease catalysis: (a) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 at ph 5 1hay 
Snapshots of serine protease catalysis: (b) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to ph 10 for 10 seconds 1haz 
Snapshots of serine protease catalysis: (c) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to ph 9 for 1 minute 1hb0 
Snapshots of serine protease catalysis: (d) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to ph 10 for 2 minutes 1hbt 
Human alpha-thrombin complexed with a peptidyl pyridinium methyl ketone containing bivalent inhibitor 1hcg 
Structure of human des(1-45) factor xa at 2.2 angstroms resolution 1hdt 
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin 1hfd 
Human complement factor d in a p21 crystal form 1hgt 
Structure of the hirugen and hirulog 1 complexes of alpha- thrombin 1hia 
Kallikrein complexed with hirustasin 1hj8 
1.00 aa trypsin from atlantic salmon 1hj9 
Atomic resolution structures of trypsin provide insight into structural radiation damage 1hja 
Lys 18 variant of turkey ovomucoid inhibitor third domain complexed with alpha-chymotrypsin 1hlt 
The structure of a nonadecapeptide of the fifth egf domain of thrombomodulin complexed with thrombin 1hne 
Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-angstroms resolution 1hrt 
The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8 angstroms resolution 1hut 
The structure of alpha-thrombin inhibited by a 15-mer single-stranded dna aptamer 1hv7 
Porcine pancreatic elastase complexed with gw311616a 1hxe 
Serine protease 1hxf 
Human thrombin complex with hirudin variant 1hyl 
The 1.8 a structure of collagenase from hypoderma lineatum 1iau 
Human granzyme b in complex with ac-iepd-cho 1id5 
Crystal structure of bovine thrombin complex with protease inhibitor ecotin 1ihs 
Crystal structure of the complex of human alpha-thrombin and non-hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 1iht 
Crystal structure of the complex of human alpha-thrombin and non-hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 1inc 
Crystal structures of the complex of porcine pancreatic elastase with two valine-derived benzoxazinone inhibitors 1ioe 
Human coagulation factor xa in complex with m55532 1iqe 
Human coagulation factor xa in complex with m55590 1iqf 
Human coagulation factor xa in complex with m55165 1iqg 
Human coagulation factor xa in complex with m55159 1iqh 
Human coagulation factor xa in complex with m55143 1iqi 
Human coagulation factor xa in complex with m55125 1iqj 
Human coagulation factor xa in complex with m55124 1iqk 
Human coagulation factor xa in complex with m55113 1iql 
Human coagulation factor xa in complex with m54476 1iqm 
Human coagulation factor xa in complex with m54471 1iqn 
Human coagulation factor xa in complex with m55192 1j14 
Benzamidine in complex with rat trypsin mutant x99rt 1j15 
Benzamidine in complex with rat trypsin mutant x99/175/190rt 1j16 
Benzamidine in complex with rat trypsin mutant x99/175/190rt 1j17 
Factor xa specific inhibitor in complex with rat trypsin mutant x99/175/190rt 1j8a 
Crystal structure of benzamidine inhibited bovine pancreatic trypsin at 105k to 1.21a resolution from laboratory source with high number of waters modelled 1j9c 
Crystal structure of tissue factor-factor viia complex 1jbu 
Coagulation factor vii zymogen (egf2/protease) in complex with inhibitory exosite peptide a-183 1jim 
Stereospecific reaction of 3-methoxy-4-chloro-7- aminoisocoumarin with crystalline porcine pancreatic elastase 1jir 
Crystal structure of trypsin complex with amylamine in cyclohexane 1jmo 
Crystal structure of the heparin cofactor ii-s195a thrombin complex 1jou 
Crystal structure of native s195a thrombin with an unoccupied active site 1jrs 
Hemiacetal complex between leupeptin and trypsin 1jrt 
Hemiacetal complex between leupeptin and trypsin 1jwt 
Crystal structure of thrombin in complex with a novel bicyclic lactam inhibitor 1k1i 
Bovine trypsin-inhibitor complex 1k1j 
Bovine trypsin-inhibitor complex 1k1l 
Bovine trypsin-inhibitor complex 1k1m 
Bovine trypsin-inhibitor complex 1k1n 
Bovine trypsin-inhibitor complex 1k1o 
Bovine trypsin-inhibitor complex 1k1p 
Bovine trypsin-inhibitor complex 1k21 
Human thrombin-inhibitor complex 1k22 
Human thrombin-inhibitor complex 1k2i 
Crystal structure of gamma-chymotrypsin in complex with 7- hydroxycoumarin 1k9o 
Crystal structure of michaelis serpin-trypsin complex 1kdq 
Crystal structure analysis of the mutant s189d rat chymotrypsin 1kig 
Bovine factor xa 1kli 
Cofactor-and substrate-assisted activation of factor viia 1klj 
Crystal structure of uninhibited factor viia 1klt 
Crystal structure of pmsf-treated human chymase at 1.9 angstroms resolution 1ksn 
Crystal structure of human coagulation factor xa complexed with fxv673 1kts 
Thrombin inhibitor complex 1ktt 
Thrombin inhibitor complex 1kye 
Factor xa in complex with (r)-2-(3-adamantan-1-yl-ureido)-3- (3-carbamimidoyl-phenyl)-n-phenethyl-propionamide 1kyn 
Cathepsin-g 1l0z 
The structure of porcine pancreatic elastase complexed with xenon and bromide, cryoprotected with dry paraffin oil 1l1g 
The structure of porcine pancreatic elastase complexed with xenon and bromide, cryoprotected with glycerol 1l2e 
Human kallikrein 6 (hk6) active form with benzamidine inhibitor 1l4d 
Crystal structure of microplasminogen-streptokinase alpha domain complex 1l4z 
X-ray crystal structure of the complex of microplasminogen with alpha domain of streptokinase in the presence cadmium ions 1ldt 
Complex of leech-derived tryptase inhibitor with porcine trypsin 1lhc 
Human alpha-thrombin complexed with ac-(d)phe-pro-boroarg-oh 1lhd 
Human alpha-thrombin complexed with ac-(d)phe-pro-borolys-oh 1lhe 
Human alpha-thrombin complexed with ac-(d)phe-pro-boro-n- butyl-amidino-glycine-oh 1lhf 
Human alpha-thrombin complexed with ac-(d)phe-pro-boro- homolys-oh 1lhg 
Human alpha-thrombin complexed with ac-(d)phe-pro- boroornithine-oh 1lka 
Porcine pancreatic elastase/ca-complex 1lkb 
Porcine pancreatic elastase/na-complex 1lmw 
Lmw u-pa structure complexed with egrcmk (glu-gly-arg chloromethyl ketone) 1lo6 
Human kallikrein 6 (hk6) active form with benzamidine inhibitor at 1.56 a resolution 1lpg 
Crystal structure of fxa in complex with 79. 1lpk 
Crystal structure of fxa in complex with 125. 1lpz 
Crystal structure of fxa in complex with 41. 1lqd 
Crystal structure of fxa in complex with 45. 1lqe 
Crystal structure of trypsin in complex with 79. 1lto 
Human alpha1-tryptase 1lvy 
Porcine elastase 1m9u 
Crystal structure of earthworm fibrinolytic enzyme component a from eisenia fetida 1max 
Beta-trypsin phosphonate inhibited 1may 
Beta-trypsin phosphonate inhibited 1mbq 
Anionic trypsin from pacific chum salmon 1mct 
The refined 1.6 angstroms resolution crystal structure of the complex formed between porcine beta-trypsin and mcti-a, a trypsin inhibitor of squash family 1mcv 
Crystal structure analysis of a hybrid squash inhibitor in complex with porcine pancreatic elastase 1md7 
Monomeric structure of the zymogen of complement protease c1r 1md8 
Monomeric structure of the active catalytic domain of complement protease c1r 1mh0 
Crystal structure of the anticoagulant slow form of thrombin 1mkw 
The co-crystal structure of unliganded bovine alpha- thrombin and prethrombin-2: movement of the yppw segment and active site residues upon ligand binding 1mkx 
The co-crystal structure of unliganded bovine alpha- thrombin and prethrombin-2: movement of the yppw segment and active site residues upon ligand binding 1mmj 
Porcine pancreatic elastase complexed with a potent peptidyl inhibitor, fr136706 1mq5 
Crystal structure of 3-chloro-n-[4-chloro-2-[[(4- chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1- piperazinyl)methyl]-2-thiophenecarboxamide complexed with human factor xa 1mq6 
Crystal structure of 3-chloro-n-[4-chloro-2-[[(5-chloro-2- pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5- dihydro-2-oxazolyl)methylamino]methyl]-2- thiophenecarboxamide complexed with human factor xa 1mtn 
Bovine alpha-chymotrypsin:bpti crystallization 1mts 
Factor xa specific inhibitor in complex with bovine trypsin 1mtu 
Factor xa specific inhibitor in complex with bovine trypsin 1mtv 
Factor xa specific inhibitor in complex with bovine trypsin 1mtw 
Factor xa specific inhibitor in complex with bovine trypsin 1mu6 
Crystal structure of thrombin in complex with l-378,622 1mu8 
Thrombin-hirugen_l-378,650 1mue 
Thrombin-hirugen-l405,426 1mza 
Crystal structure of human pro-granzyme k 1mzd 
Crystal structure of human pro-granzyme k 1n6x 
Rip-phasing on bovine trypsin 1n6y 
Rip-phasing on bovine trypsin 1n8o 
Crystal structure of a complex between bovine chymotrypsin and ecotin 1nc6 
Potent, small molecule inhibitors of human mast cell tryptase. anti-asthmatic action of a dipeptide-based transition state analogue containing benzothiazole ketone 1nes 
Structure of the product complex of acetyl-ala-pro-ala with porcine pancreatic elastase at 1.65 angstroms resolution 1nfu 
Crystal structure of human coagulation factor xa complexed with rpr132747 1nfw 
Crystal structure of human coagulation factor xa complexed with rpr209685 1nfx 
Crystal structure of human coagulation factor xa complexed with rpr208944 1nfy 
Crystal structure of human coagulation factor xa complexed with rpr200095 1nm6 
Thrombin in complex with selective macrocyclic inhibitor at 1.8a 1nn6 
Human pro-chymase 1no9 
Design of weakly basic thrombin inhibitors incorporating novel p1 binding functions: molecular and x-ray crystallographic studies. 1npm 
Neuropsin, a serine protease expressed in the limbic system of mouse brain 1nrn 
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes 1nro 
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes 1nrp 
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes 1nrq 
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes 1nrr 
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes 1nrs 
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes 1nt1 
Thrombin in complex with selective macrocyclic inhibitor 1ntp 
Use of the neutron diffraction h/d exchange technique to determine the conformational dynamics of trypsin 1nu7 
Staphylocoagulase-thrombin complex 1nu9 
Staphylocoagulase-prethrombin-2 complex 1ny2 
Human alpha thrombin inhibited by rppgf and hirugen 1nzq 
D-phe-pro-arg-type thrombin inhibitor 1o0d 
Human thrombin complexed with a d-phe-pro-arg-type inhibitor and a c-terminal hirudin derived exo-site inhibitor 1o2g 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2h 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2i 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2j 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2k 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2l 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2m 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2n 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2o 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2p 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2q 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2r 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2s 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2t 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2u 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2v 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2w 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2x 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2y 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o2z 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o30 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o31 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o32 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o33 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o34 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o35 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o36 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o37 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o38 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o39 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3a 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3b 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3c 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3d 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3e 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3f 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3g 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3h 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3i 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3j 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3k 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3l 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3m 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3n 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3o 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o3p 
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors 1o5a 
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) 1o5b 
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) 1o5c 
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) 1o5d 
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) 1o5e 
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) 1o5f 
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) 1o5g 
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) 1okx 
Binding structure of elastase inhibitor scyptolin a 1ook 
Crystal structure of the complex of platelet receptor gpib- alpha and human alpha-thrombin 1op0 
Crystal structure of aav-sp-i, a glycosylated snake venom serine proteinase from agkistrodon acutus 1op2 
Crystal structure of aav-sp-ii, a glycosylated snake venom serine proteinase from agkistrodon acutus 1op8 
Crystal structure of human granzyme a 1oph 
Non-covalent complex between alpha-1-pi-pittsburgh and s195a trypsin 1orf 
The oligomeric structure of human granzyme a reveals the molecular determinants of substrate specificity 1os8 
Recombinant streptomyces griseus trypsin 1oss 
T190p streptomyces griseus trypsin in complex with benzamidine 1owd 
Substituted 2-naphthamidine inhibitors of urokinase 1owe 
Substituted 2-naphthamidine inhibitors of urokinase 1owh 
Substituted 2-naphthamidine inhibitors of urokinase 1owi 
Substituted 2-naphthamidine inhibitors of urokinase 1owj 
Substituted 2-naphthamidine inhibitors of urokinase 1owk 
Substituted 2-naphthamidine inhibitors of urokinase 1ox1 
Crystal structure of the bovine trypsin complex with a synthetic 11 peptide inhibitor 1oxg 
Crystal structure of a complex formed between organic solvent treated bovine alpha-chymotrypsin and its autocatalytically produced highly potent 14-residue peptide at 2.2 resolution 1oyq 
Trypsin inhibitor complex 1oyt 
Complex of recombinant human thrombin with a designed fluorinated inhibitor 1p0s 
Crystal structure of blood coagulation factor xa in complex with ecotin m84r 1p2i 
Structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin 1p2j 
Structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin 1p2k 
Structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin 1p2m 
Structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin 1p2n 
Structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin 1p2o 
Structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin 1p2q 
Structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin 1p3c 
Glutamyl endopeptidase from bacillus intermedius 1p3e 
Structure of glu endopeptidase in complex with mpd 1p57 
Extracellular domain of human hepsin 1p8v 
Crystal structure of the complex of platelet receptor gpib- alpha and alpha-thrombin at 2.6a 1pfx 
Porcine factor ixa 1pjp 
The 2.2 a crystal structure of human chymase in complex with succinyl-ala-ala-pro-phe-chloromethylketone 1ppb 
The refined 1.9 angstroms crystal structure of human alpha- thrombin: interaction with d-phe-pro-arg chloromethylketone and significance of the tyr-pro-pro-trp insertion segment 1ppc 
Geometry of binding of the benzamidine-and arginine-based inhibitors n-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p- amidinophenylalanyl-piperidine (napap) and (2r,4r)-4- methyl-1-[n-alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-l-arginyl]-2-piperidine carboxylic acid (mqpa) to human alpha-thrombin: x-ray crystallographic determination of the napap-trypsin complex and modeling of napap-thrombin and mqpa-thrombin 1ppe 
The refined 2.0 angstroms x-ray crystal structure of the complex formed between bovine beta-trypsin and cmti-i, a trypsin inhibitor from squash seeds (cucurbita maxima): topological similarity of the squash seed inhibitors with the carboxypeptidase a inhibitor from potatoes 1ppf 
X-ray crystal structure of the complex of human leukocyte elastase (pmn elastase) and the third domain of the turkey ovomucoid inhibitor 1ppg 
The refined 2.3 angstroms crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor 1pph 
Geometry of binding of the nalpha-tosylated piperidides of m-amidino-, p-amidino-and p-guanidino phenylalanine to thrombin and trypsin: x-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes 1ppz 
Trypsin complexes at atomic and ultra-high resolution 1pq5 
Trypsin at ph 5, 0.85 a 1pq7 
Trypsin at 0.8 a, ph5 / borax 1pq8 
Trypsin at ph 4 at atomic resolution 1pqa 
Trypsin with pmsf at atomic resolution 1pyt 
Ternary complex of procarboxypeptidase a, proproteinase e, and chymotrypsinogen c 1q3x 
Crystal structure of the catalytic region of human masp-2 1qa0 
Bovine trypsin 2-aminobenzimidazole complex 1qb1 
Bovine trypsin with 1-[2-[5-[amino(imino)methyl]-2- hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1h-imidazol-2- yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic acid (zk- 806974) 1qb6 
Bovine trypsin 3,3'-[3,5-difluoro-4-methyl-2, 6- pyridinediylbis(oxy)]bis(benzenecarboximidamide) (zk- 805623) complex 1qb9 
Bovine trypsin 7-[[2-[[1-(1-iminoethyl)piperidin-4-yl]oxy]- 9h-carbozol-9-yl] methyl]naphthalene-2-carboximidamide (zk- 806450) complex 1qbn 
Bovine trypsin 2-[amino(imino)methyl]-2-hydroxyphenoxy]-6- [3-(4,5-dihydro-1h-imidazol-2-yl)phenoxy]pyridine-4- carboxylic acid (zk-806688) complex 1qbo 
Bovine trypsin 7-[[6-[[1-(1-iminoethyl)piperidin-4-yl]oxy]- 2-methyl-benzimidazol-1-yl]methyl]naphthalene-2- carboximidamid zk-806711 inhibitor complex 1qbv 
Crystal structure of thrombin complexed with an guanidine- mimetic inhibitor 1qcp 
Crystal structure of the rwj-51084 bovine pancreatic beta- trypsin at 1.8 a 1qfk 
Structure of human factor viia and its implications for the triggering of blood coagulation 1qgf 
Porcine pancreatic elastase complexed with (3r, 4s)n-para- toluenesulphonyl-3-ethyl-4-(carboxylic acid)pyrrolidin-2- one 1qhr 
Novel covalent active site thrombin inhibitors 1qix 
Porcine pancreatic elastase complexed with human beta-casomorphin-7 1qj1 
Novel covalent active site thrombin inhibitors 1qj6 
Novel covalent active site thrombin inhibitors 1qj7 
Novel covalent active site thrombin inhibitors 1ql7 
Factor xa specific inhibitor in complex with bovine trypsin 1ql8 
Factor xa specific inhibitor in complex with bovine trypsin 1ql9 
Factor xa specific inhibitor in complex with rat trypsin mutant x99rt 1qnj 
The structure of native porcine pancreatic elastase at atomic resolution (1.1 a) 1qqu 
Crystal structure of porcine beta trypsin with bound acetate ion 1qr3 
Structure of porcine pancreatic elastase in complex with fr901277, a novel macrocyclic inhibitor of elastases at 1.6 angstrom resolution 1qrz 
Catalytic domain of plasminogen 1qur 
Human alpha-thrombin in complex with bivalent, benzamidine- based synthetic inhibitor 1qy6 
Structue of v8 protease from staphylococcus aureus 1rd3 
2.5a structure of anticoagulant thrombin variant e217k 1rfn 
Human coagulation factor ixa in complex with p-amino benzamidine 1riw 
Thrombin in complex with natural product inhibitor oscillarin 1rjx 
Human plasminogen catalytic domain, k698m mutant 1rrk 
Crystal structure analysis of the bb segment of factor b 1rs0 
Crystal structure analysis of the bb segment of factor b complexed with di-isopropyl-phosphate (dip) 1rtf 
Complex of benzamidine with the catalytic domain of human two chain tissue plasminogen activator [(tc)-t-pa] 1rtk 
Crystal structure analysis of the bb segment of factor b complexed with 4-guanidinobenzoic acid 1rxp 
Structure of trypsin (orthorhombic) with 1-(4-tert- butylcarbamoyl- piperazine-1-carbonyl)-3-(3-guanidino- propyl)-4-oxo-azetidine-2-carboxylic acid 1s0q 
Native bovine pancreatic trypsin 1s0r 
Bovine pancreatic trypsin inhibited with benzamidine at atomic resolution 1s5s 
Porcine trypsin complexed with guanidine-3-propanol inhibitor 1s6f 
Porcine trypsin covalent complex with borate and guanidine- inhibitor 1s6h 
Porcine trypsin complexed with guanidine-3-propanol inhibitor 1s81 
Porcine trypsin with no inhibitor bound 1s82 
Porcine trypsin complexed with borate and ethylene glycol 1s83 
Porcine trypsin complexed with 4-amino propanol 1s84 
Porcine trypsin covalent complex with 4-amino butanol, borate and ethylene glycol 1s85 
Porcine trypsin complexed with p-hydroxymethyl benzamidine and borate 1sb1 
Novel non-covalent thrombin inhibitors incorporating p1 4,5, 6,7-tetrahydrobenzothiazole arginine side chain mimetics 1sbw 
Crystal structure of mung bean inhibitor lysine active fragment complex with bovine beta-trypsin at 1.8a resolution 1sc8 
Urokinase plasminogen activator b-chain-j435 complex 1sfi 
High resolution structure of a potent, cyclic protease inhibitor from sunflower seeds 1sfq 
Fast form of thrombin mutant r(77a)a bound to ppack 1sg8 
Crystal structure of the procoagulant fast form of thrombin 1sgc 
The 1.8 angstroms structure of the complex between chymostatin and streptomyces griseus protease a. a model for serine protease catalytic tetrahedral intermediates 1sgd 
Asp 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 6.5 1sge 
Glu 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 6.5 1sgf 
Crystal structure of 7s ngf: a complex of nerve growth factor with four binding proteins (serine proteinases) 1sgi 
Crystal structure of the anticoagulant slow form of thrombin 1sgn 
Asn 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b 1sgp 
Ala 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b 1sgq 
Gly 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b 1sgr 
Leu 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b 1sgt 
Refined crystal structure of streptomyces griseus trypsin at 1.7 angstroms resolution 1sgy 
Tyr 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 6.5 1shh 
Slow form of thrombin bound with ppack 1shy 
The crystal structure of hgf beta-chain in complex with the sema domain of the met receptor. 1si5 
Protease-like domain from 2-chain hepatocyte growth factor 1sl3 
Crystal structue of thrombin in complex with a potent p1 heterocycle-aryl based inhibitor 1slu 
Rat anionic n143h, e151h trypsin complexed to a86h ecotin 1slv 
Rat anionic n143h, e151h trypsin complexed to a86h ecotin; copper-bound 1slw 
Rat anionic n143h, e151h trypsin complexed to a86h ecotin; nickel-bound 1slx 
Rat anionic n143h, e151h trypsin complexed to a86h ecotin; zinc-bound 1smf 
Studies on an artificial trypsin inhibitor peptide derived from the mung bean inhibitor 1spj 
Structure of mature human tissue kallikrein (human kallikrein 1 or klk1) at 1.70 angstrom resolution with vacant active site 1sqa 
Substituted 2-naphthamidine inhibitors of urokinase 1sqo 
Substituted 2-naphthamidine inhibitors of urokinase 1sqt 
Substituted 2-naphthamidine inhibitors of urokinase 1sr5 
Antithrombin-anhydrothrombin-heparin ternary complex structure 1t31 
A dual inhibitor of the leukocyte proteases cathepsin g and chymase with therapeutic efficacy in animals models of inflammation 1t32 
A dual inhibitor of the leukocyte proteases cathepsin g and chymase with therapeutic efficacy in animals models of inflammation 1t4u 
Crystal structure analysis of a novel oxyguanidine bound to thrombin 1t4v 
Crystal structure analysis of a novel oxyguanidine bound to thrombin 1t7c 
Crystal structure of the p1 glu bpti mutant- bovine chymotrypsin complex 1t8l 
Crystal structure of the p1 met bpti mutant- bovine chymotrypsin complex 1t8m 
Crystal structure of the p1 his bpti mutant- bovine chymotrypsin complex 1t8n 
Crystal structure of the p1 thr bpti mutant- bovine chymotrypsin complex 1t8o 
Crystal structure of the p1 trp bpti mutant- bovine chymotrypsin complex 1ta2 
Crystal structure of thrombin in complex with compound 1 1ta6 
Crystal structure of thrombin in complex with compound 14b 1tab 
Structure of the trypsin-binding domain of bowman-birk type protease inhibitor and its interaction with trypsin 1taw 
Bovine trypsin complexed to appi 1tb6 
2.5a crystal structure of the antithrombin-thrombin-heparin ternary complex 1tbq 
Crystal structure of insect derived double domain kazal inhibitor rhodniin in complex with thrombin 1tbr 
Crystal structure of insect derived double domain kazal inhibitor rhodniin in complex with thrombin 1tbz 
Human thrombin with active site n-methyl-d phenylalanyl-n- [5-(aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl] butyl]-l-prolinamide trifluroacetate and exosite-hirugen 1tfx 
Complex of the second kunitz domain of tissue factor pathway inhibitor with porcine trypsin 1tgb 
Crystal structure of bovine trypsinogen at 1.8 angstroms resolution. ii. crystallographic refinement, refined crystal structure and comparison with bovine trypsin 1tgc 
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography 1tgn 
Structure of bovine trypsinogen at 1.9 angstroms resolution 1tgs 
Three-dimensional structure of the complex between pancreatic secretory inhibitor (kazal type) and trypsinogen at 1.8 angstroms resolution. structure solution, crystallographic refinement and preliminary structural interpretation 1tgt 
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography 1thp 
Structure of human alpha-thrombin y225p mutant bound to d- phe-pro-arg-chloromethylketone 1thr 
Structures of thrombin complexes with a designed and a natural exosite inhibitor 1ths 
Structures of thrombin complexes with a designed and a natural exosite inhibitor 1tio 
High packing density form of bovine beta-trypsin in cyclohexane 1tld 
Crystal structure of bovine beta-trypsin at 1.5 angstroms resolution in a crystal form with low molecular packing density. active site geometry, ion pairs and solvent structure 1tmb 
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide a 1tmt 
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms 1tmu 
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms 1tng 
Prediction of novel serine protease inhibitors 1tnh 
Prediction of novel serine protease inhibitors 1tni 
Prediction of novel serine protease inhibitors 1tnj 
Prediction of novel serine protease inhibitors 1tnk 
Prediction of novel serine protease inhibitors 1tnl 
Prediction of novel serine protease inhibitors 1toc 
Structure of serine proteinase 1tom 
Alpha-thrombin complexed with hirugen 1ton 
Rat submaxillary gland serine protease, tonin. structure solution and refinement at 1.8 angstroms resolution 1tpa 
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors 1tpo 
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors 1tpp 
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors 1tps 
Atomic structure of the trypsin-a90720a complex: a unified approach to structure and function 1tq0 
Crystal structure of the potent anticoagulant thrombin mutant w215a/e217a in free form 1tq7 
Crystal structure of the anticoagulant thrombin mutant w215a/e217a bound to ppack 1trm 
The three-dimensional structure of asn102 mutant of trypsin. role of asp102 in serine protease catalysis 1trn 
Crystal structure of human trypsin 1: unexpected phosphorylation of tyrosine 151 1try 
Structure of inhibited trypsin from fusarium oxysporum at 1.55 angstroms 1twx 
Crystal structure of the thrombin mutant d221a/d222k 1tx6 
Trypsin:bbi complex 1tx7 
Bovine trypsin complexed with p- amidinophenylmethylphosphinic acid (ampa) 1tx8 
Bovine trypsin complexed with amso 1tyn 
Atomic structure of the trypsin-cyclotheonamide a complex: lessons for the design of serine protease inhibitors 1u6q 
Substituted 2-naphthamadine inhibitors of urokinase 1ucy 
Thrombin complexed with fibrinopeptide a alpha (residues 7- 19). three complexes, one with epsilon-thrombin and two with alpha-thrombin 1uhb 
Crystal structure of porcine alpha trypsin bound with auto catalyticaly produced native peptide at 2.15 a resolution 1uma 
Alpha-thrombin (hirugen) complexed with na-(n,n- dimethylcarbamoyl)-alpha-azalysine 1uo6 
Porcine pancreatic elastase/xe-complex 1utj 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1utk 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1utl 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1utm 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1utn 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1uto 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1utp 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1utq 
Trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements 1uvo 
Structure of the complex of porcine pancreatic elastase in complex with cadmium refined at 1.85 a resolution (crystal a) 1uvp 
Structure of the complex of porcine pancreatic elastase in complex with cadmium refined at 1.85 a resolution (crystal b) 1uvs 
Bovine thrombin--bm51.1011 complex 1uvt 
Bovine thrombin--bm14.1248 complex 1uvu 
Bovine thrombin--bm12.1700 complex 1v2j 
Benzamidine in complex with bovine trypsin variant x(ssri) bt.c1 1v2k 
Factor xa specific inhibitor in complex with bovine trypsin variant x(triple.glu)bt.d2 1v2l 
Benzamidine in complex with bovine trypsin variant x(triple.glu)bt.d1 1v2m 
Benzamidine in complex with bovine trypsin variant x(triple.glu)bt.a1 1v2n 
Potent factor xa inhibitor in complex with bovine trypsin variant x(99/175/190)bt 1v2o 
Trypsin inhibitor in complex with bovine trypsin variant x(ssyi)bt.b4 1v2p 
Trypsin inhibitor in complex with bovine trypsin variant x(ssyi)bt.a4 1v2q 
Trypsin inhibitor in complex with bovine trypsin variant x(sswi)bt.b4 1v2r 
Trypsin inhibitor in complex with bovine trypsin variant x(ssri)bt.b4 1v2s 
Benzamidine in complex with bovine trypsin variant x(ssfi.glu)bt.d1 1v2t 
Trypsin inhibitor in complex with bovine trypsin variant x(ssfi.glu)bt.b4 1v2u 
Benzamidine in complex with bovine trypsin varinat x(ssai) bt.d1 1v2v 
Benzamidine in complex with bovine trypsin variant x(ssai) bt.c1 1v2w 
Trypsin inhibitor in complex with bovine trypsin variant x(ssai)bt.b4 1v3x 
Factor xa in complex with the inhibitor 1-[6-methyl-4,5,6,7- tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2- carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine 1v6d 
The crystal structure of the trypsin complex with synthetic heterochiral peptide 1vgc 
Gamma-chymotrypsin l-para-chloro-1-acetamido boronic acid inhibitor complex 1vit 
Thrombin:hirudin 51-65 complex 1vj9 
Urokinase plasminogen activator b-chain-jt464 complex 1vja 
Urokinase plasminogen activator b-chain-jt464 complex 1vr1 
Specifity for plasminogen activator inhibitor-1 1vzq 
Complex of thrombin with designed inhibitor 7165 1w0y 
Tf7a_3771 complex 1w0z 
Urokinase type plasminogen activator 1w10 
Urokinase type plasminogen activator 1w11 
Urokinase type plasminogen activator 1w12 
Urokinase type plasminogen activator 1w13 
Urokinase type plasminogen activator 1w14 
Urokinase type plasminogen activator 1w2k 
Tf7a_4380 complex 1w7g 
Alpha-thrombin complex with sulfated hirudin (residues 54- 65) and l-arginine template inhibitor cs107 1w7x 
Factor7- 413 complex 1w8b 
Factor7 - 413 complex 1way 
Active site thrombin inhibitors 1wbg 
Active site thrombin inhibitors 1wcz 
Crystal structure of an alkaline form of v8 protease from staphylococcus aureus 1wqv 
Human factor viia-tissue factor complexed with propylsulfonamide-d-thr-met-p-aminobenzamidine 1wss 
Human factor viia-tissue factor in complex with peprid mimetic inhibitor that has two charge groups in p2 and p4 1wtg 
Human factor viia-tissue factor complexed with ethylsulfonamide-d-biphenylalanine-gln-p-aminobenzamidine 1wu1 
Factor xa in complex with the inhibitor 4-[(5-chloroindol-2- yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine 1wun 
Human factor viia-tissue factor complexed with ethylsulfonamide-d-trp-gln-p-aminobenzamidine 1wv7 
Human factor viia-tissue factor complexed with ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine 1x7a 
Porcine factor ixa complexed to 1-{3-[amino(imino) methyl]phenyl}-n-[4-(1h-benzimidazol-1-yl)-2-fluorophenyl]- 3-(trifluoromethyl)-1h-pyrazole-5-carboxamide 1xka 
Factor xa complexed with a synthetic inhibitor fx-2212a, (2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid 1xkb 
Factor xa complexed with a synthetic inhibitor fx-2212a, (2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid 1xm1 
Nonbasic thrombin inhibitor complex 1xmn 
Crystal structure of thrombin bound to heparin 1xuf 
Trypsin-babim-zn+2, ph 8.2 1xug 
Trypsin-babim-zn+2, ph 8.2 1xuh 
Trypsin-keto-babim-co+2, ph 8.2 1xui 
Trypsin-keto-babim, zn+2-free, ph 8.2 1xuj 
Trypsin-keto-babim-zn+2, ph 8.2 1xuk 
Trypsin-babim-sulfate, ph 5.9 1xvm 
Trypsin from fusarium oxysporum- room temperature to atomic resolution 1xvo 
Trypsin from fusarium oxysporum at ph 6 1xx9 
Crystal structure of the fxia catalytic domain in complex with ecotinm84r 1xxd 
Crystal structure of the fxia catalytic domain in complex with mutated ecotin 1xxf 
Crystal structure of the fxia catalytic domain in complex with ecotin mutant (ecotinp) 1y3u 
Trypsin inhibitor complex 1y3v 
Trypsin inhibitor complex 1y3w 
Trypsin inhibitor complex 1y3x 
Trypsin inhibitor complex 1y3y 
Trypsin inhibitor complex 1y59 
Dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant 1y5a 
Dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant 1y5b 
Dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant 1y5u 
Dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant 1ybw 
Protease domain of hgfa with no inhibitor 1yc0 
Short form hgfa with first kunitz domain from hai-1 1ycp 
The crystal structure of fibrinogen-aa peptide 1-23 (f8y) bound to bovine thrombin explains why the mutation of phe- to tyrosine strongly inhibits normal cleavage at arginine-16 1yf4 
Crystal structure of trypsin-vasopressin complex 1ygc 
Short factor viia with a small molecule inhibitor 1ykt 
Trypsin/bpti complex mutant 1ylc 
Trypsin/bpti complex mutant 1yld 
Trypsin/bpti complex mutant 1ym0 
Crystal structure of earthworm fibrinolytic enzyme component b: a novel, glycosylated two-chained trypsin 1yp9 
Trypsin inhibitor complex 1ype 
Thrombin inhibitor complex 1ypg 
Thrombin inhibitor complex 1yph 
High resolution structure of bovine alpha-chymotrypsin 1ypj 
Thrombin inhibitor complex 1ypk 
Thrombin inhibitor complex 1ypl 
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue ra-1008 1ypm 
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue ra-1014 1yyy 
Trypsin inhibitors with rigid tripeptidyl aldehydes 1z6e 
Crystal structure of factor xa complexed to razaxaban 1z6j 
Crystal structure of a ternary complex of factor viia/tissue factor/pyrazinone inhibitor 1z71 
Thrombin and p2 pyridine n-oxide inhibitor complex structure 1z7k 
Crystal structure of trypsin- ovomucoid turkey egg white inhibitor complex 1z8g 
Crystal structure of the extracellular region of the transmembrane serine protease hepsin with covalently bound preferred substrate. 1z8i 
Crystal structure of the thrombin mutant g193a bound to ppack 1z8j 
Crystal structure of the thrombin mutant g193p bound to ppack 1zgi 
Thrombin in complex with an oxazolopyridine inhibitor 21 1zgv 
Thrombin in complex with an oxazolopyridine inhibitor 2 1zhm 
Crystal structure of the catalytic domain of the coagulation factor xia in complex with benzamidine (s434a- t475a-k437 mutant) 1zhp 
Crystal structure of the catalytic domain of coagulation factor xi in complex with benzamidine (s434a-t475a-k505 mutant) 1zhr 
Crystal structure of the catalytic domain of coagulation factor xi in complex with benzamidine (s434a-t475a-c482s- k437a mutant) 1zjd 
Crystal structure of the catalytic domain of coagulation factor xi in complex with kunitz protease inhibitor domain of protease nexin ii 1zjk 
Crystal structure of the zymogen catalytic region of human masp-2 1zlr 
Factor xi catalytic domain complexed with 2-guanidino-1-(4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl nicotinate 1zmj 
Crystal structure of the catalytic domain of factor xi in complex with 4-(guanidinomethyl)-phenylboronic acid 1zml 
Crystal structure of the catalytic domain of factor xi in complex with (r)-1-(4-(4-(hydroxymethyl)-1,3,2- dioxaborolan-2-yl)phenethyl)guanidine 1zmn 
Crystal structure of the catalytic domain of coagulation factor xi in complex with (r)-1-(4-(4-(hydroxymethyl)-1,3, 2-dioxaborolan-2-yl)phenyl)guanidine 1zom 
Crystal structure of the catalytic domain of coagulation factor xi in complex with a peptidomimetic inhibitor 1zpb 
Crystal structure of the catalytic domain of coagulation factor xi in complex with 4-methyl-pentanoic acid {1-[4- guanidino-1-(thiazole-2-carbonyl)-butylcarbamoyl]-2-methyl- propyl}-amide 1zpc 
Crystal structure of the catalytic domain of coagulation factor xi in complex with 2-[2-(3-chloro-phenyl)-2-hydroxy- acetylamino]-n-[4-guanidino-1-(thiazole-2-carbonyl)-butyl]- 3-methyl-butyramide 1zpz 
Factor xi catalytic domain complexed with n-((r)-1-(4- bromophenyl)ethyl)urea-asn-val-arg-alpha-ketothiazole 1zr0 
Crystal structure of kunitz domain 1 of tissue factor pathway inhibitor-2 with bovine trypsin 1zrb 
Thrombin in complex with an azafluorenyl inhibitor 23b 1zrk 
Factor xi complexed with 3-hydroxypropyl 3-(7- amidinonaphthalene-1-carboxamido)benzenesulfonate 1zsj 
Crystal structure of the catalytic domain of coagulation factor xi in complex with n-(7-carbamimidoyl-naphthalen-1- yl)-3-hydroxy-2-methyl-benzamide 1zsk 
Crystal structure of the catalytic domain of coagulation factor xi in complex with 6-carbamimidoyl-4-(3-hydroxy-2- methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester 1zsl 
Factor xi complexed with a pyrimidinone inhibitor 1ztj 
Crystal structure of the catalytic domain of coagulation factor xi in complex with 2-(5-benzylamino-2- methylsulfanyl-6-oxo-6h-pyrimidin-1-yl)-n-[4-guanidino-1- (thiazole-2-carbonyl)-butyl]-acetamide 1ztk 
Crystal structure of the catalytic domain of coagulation factor xi in complex with 2-(5-amino-6-oxo-2-m-tolyl-6h- pyrimidin-1-yl)-n-[4-guanidino-1-(thiazole-2-carbonyl)- butyl]-acetamide 1ztl 
Crystal structure of the catalytic domain of coagulation factor xi in complex with n-[4-guanidino-1-(thiazole-2- carbonyl)-butyl]-2-{6-oxo-5-[(quinolin-8-ylmethyl)-amino]- 2-m-tolyl-6h-pyrimidin-1-yl}-acetamide 1zzz 
Trypsin inhibitors with rigid tripeptidyl aldehydes 2a0q 
Structure of thrombin in 400 mm potassium chloride 2a1d 
Staphylocoagulase bound to bovine thrombin 2a2q 
Complex of active-site inhibited human coagulation factor viia with human soluble tissue factor in the presence of ca2+, mg2+, na+, and zn2+ 2a2x 
Orally active thrombin inhibitors in complex with thrombin inh12 2a31 
Trypsin in complex with borate 2a32 
Trypsin in complex with benzene boronic acid 2a45 
Crystal structure of the complex between thrombin and the central "e" region of fibrin 2a7c 
On the routine use of soft x-rays in macromolecular crystallography, part iii- the optimal data collection wavelength 2a7h 
On the routine use of soft x-rays in macromolecular crystallography, part iii- the optimal data collection wavelength 2a7j 
On the routine use of soft x-rays in macromolecular crystallography, part iii- the optimal data collection wavelength 2aei 
Crystal structure of a ternary complex of factor viia/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]- 3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2- pyridinyl]oxy]-benzoic acid 2aer 
Crystal structure of benzamidine-factor viia/soluble tissue factor complex. 2afq 
1.9 angstrom crytal structure of wild-type human thrombin in the sodium free state 2age 
Succinyl-aapr-trypsin acyl-enzyme at 1.15 a resolution 2agg 
Succinyl-aapk-trypsin acyl-enzyme at 1.28 a resolution 2agi 
The leupeptin-trypsin covalent complex at 1.14 a resolution 2ah4 
Guanidinobenzoyl-trypsin acyl-enzyme at 1.13 a resolution 2aip 
Crystal structure of native protein c activator from the venom of copperhead snake agkistrodon contortrix contortrix 2aiq 
Crystal structure of benzamidine-inhibited protein c activator from the venom of copperhead snake agkistrodon contortrix contortrix 2ank 
Orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide 2anm 
Ternary complex of an orally active thrombin inhibitor with human thrombin and a c-terminal hirudin derived exo-sit inhibitor 2anw 
Expression, crystallization and three-dimensional structure of the catalytic domain of human plasma kallikrein: implications for structure-based design of protease inhibitors 2any 
Expression, crystallization and the three-dimensional structure of the catalytic domain of human plasma kallikrein: implications for structure-based design of protease inhibitors 2as9 
Functional and structural characterization of spl proteases from staphylococcus aureus 2asu 
Crystal structure of the beta-chain of hgfl/msp 2ayw 
Crystal structure of the complex formed between trypsin and a designed synthetic highly potent inhibitor in the presence of benzamidine at 0.97 a resolution 2b5t 
2.1 angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic sr123781 and two s195a thrombin molecules 2b7d 
Factor viia inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in a baboon thrombosis model 2b8o 
Crystal structure of glu-gly-arg-chloromethyl ketone-factor viia/soluble tissue factor complex 2b9l 
Crystal structure of prophenoloxidase activating factor-ii from the beetle holotrichia diomphalia 2bb4 
Porcine pancreatic elastase complexed with beta-casomorphin- and asp-phe at ph 5.0 2bd2 
Porcine pancreatic elastase complexed with beta-casomorphin- and arg-phe at ph 5.0 2bd3 
Porcine pancreatic elastase complexed with beta-casomorphin- and lys-ala-nh2 at ph 5.0 2bd4 
Porcine pancreatic elastase complexed with beta-casomorphin- and lys-ser at ph 5.0 2bd5 
Porcine pancreatic elastase complexed with beta-casomorphin- and lys-ser at ph 5 and immersed in ph 9 buffer for 30 seconds 2bd7 
Porcine pancreatic elastase complexed with beta-casomorphin- and arg-phe at ph 5.0 (50 min soak) 2bd8 
Porcine pancreatic elastase complexed with beta-casomorphin- and arg-phe at ph 5.0 (50 min soak) and immersed in ph 9 buffer for 30 seconds 2bd9 
Porcine pancreatic elastase complexed with beta-casomorphin- and arg-phe at ph 5.0 (50 min soak) and immersed in ph 9 buffer for 28 seconds (2nd ph jump) 2bda 
Porcine pancreatic elastase complexed with n-acetyl-npi and ala-ala at ph 5.0 2bdb 
Porcine pancreatic elastase complexed with asn-pro-ile and ala-ala at ph 5.0 2bdc 
Porcine pancreatic elastase complexed with asn-pro-ile at ph 5.0 2bdg 
Human kallikrein 4 complex with nickel and p- aminobenzamidine 2bdh 
Human kallikrein 4 complex with zinc and p-aminobenzamidine 2bdi 
Human kallikrein 4 complex with cobalt and p- aminobenzamidine 2bdy 
Thrombin in complex with inhibitor 2blo 
Elastase before a high dose x-ray "burn" 2blq 
Elastase after a high dose x-ray "burn" 2blv 
Trypsin before a high dose x-ray "burn" 2blw 
Trypsin after a high dose x-ray "burn" 2bm2 
Human beta-ii tryptase in complex with 4-(3-aminomethyl- phenyl)-piperidin-1-yl-(5-phenethyl- pyridin-3-yl)- methanone 2bmg 
Crystal structure of factor xa in complex with 50 2boh 
Crystal structure of factor xa in complex with compound "1" 2bok 
Factor xa - cation 2bq6 
Crystal structure of factor xa in complex with 21 2bq7 
Crystal structure of factor xa in complex with 43 2bqw 
Crystal structure of factor xa in complex with compound 45 2btc 
Bovine trypsin in complex with squash seed inhibitor (cucurbita pepo trypsin inhibitor ii) 2bvr 
Human thrombin complexed with fragment-based small molecules occupying the s1 pocket 2bvs 
Human thrombin complexed with fragment-based small molecules occupying the s1 pocket 2bvx 
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker 2bxt 
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker 2bxu 
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker 2by5 
Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection 2by6 
Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection 2by7 
Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection 2by8 
Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection 2by9 
Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection 2bya 
Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection 2bz6 
Orally available factor7a inhibitor 2bza 
Bovine pancreas beta-trypsin in complex with benzylamine 2c4f 
Crystal structure of factor vii.stf complexed with pd0297121 2c8w 
Thrombin inhibitors 2c8x 
Thrombin inhibitors 2c8y 
Thrombin inhibitors 2c8z 
Thrombin inhibitors 2c90 
Thrombin inhibitors 2c93 
Thrombin inhibitors 2cf8 
Complex of recombinant human thrombin with a inhibitor 2cf9 
Complex of recombinant human thrombin with a inhibitor 2cga 
Bovine chymotrypsinogen a. x-ray crystal structure analysis and refinement of a new crystal form at 1.8 angstroms resolution 2cha 
The structure of crystalline alpha-chymotrypsin, $v.the atomic structure of tosyl-alpha-chymotrypsin at 2 angstroms resolution 2cji 
Crystal structure of a human factor xa inhibitor complex 2cmy 
Crystal complex between bovine trypsin and veronica hederifolia trypsin inhibitor 2cn0 
Complex of recombinant human thrombin with a designed inhibitor 2cv3 
Crystal structure of porcine pancreatic elastase complexed with a macroclyclic peptide inhibitor 2d1j 
Factor xa in complex with the inhibitor 2-[[4-[(5- chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide 2d26 
Active site distortion is sufficient for proteinase inhibit second crystal structure of covalent serpin-proteinase complex 2d8w 
Structure of hyper-vil-trypsin 2de8 
Crystal structure of porcine pancreatic elastase with a unique conformation induced by tris 2de9 
Crystal structure of porcine pancreatic elastase complexed with tris after soaking a tris-free solution 2ec9 
Crystal structure analysis of human factor viia , souluble tissue factor complexed with bcx-3607 2eek 
Crystal structure of atlantic cod trypsin complexed with benzamidine 2ei6 
Factor xa in complex with the inhibitor (-)-cis-n1-[(5- chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2- cyclohexanediamine 2ei7 
Factor xa in complex with the inhibitor trans-n1-[(5- chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2- cyclohexanediamine 2ei8 
Factor xa in complex with the inhibitor (1s,2r,4s)-n1-[(5- chloroindol-2-yl)carbonyl]-4-(n,n-dimethylcarbamoyl)-n2- [(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl) carbonyl]-1,2-cyclohexanediamine 2est 
Crystallographic study of the binding of a trifluoroacetyl dipeptide anilide inhibitor with elastase 2f3c 
Crystal structure of infestin 1, a kazal-type serineprotease inhibitor, in complex with trypsin 2f83 
Crystal structure at 2.9 angstroms resolution of human plasma coagulation factor xi zymogen 2f91 
1.2a resolution structure of a crayfish trypsin complexed with a peptide inhibitor, sgti 2f9b 
Discovery of novel heterocyclic factor viia inhibitors 2f9n 
Crystal structure of the recombinant human alpha i tryptase mutant k192q/d216g in complex with leupeptin 2f9o 
Crystal structure of the recombinant human alpha i tryptase mutant d216g 2f9p 
Crystal structure of the recombinant human alpha i tryptase mutant d216g in complex with leupeptin 2fda 
Crystal structure of the catalytic domain of human coagulation factor xia in complex with alpha-ketothiazole arginine derived ligand 2feq 
Orally active thrombin inhibitors 2fes 
Orally active thrombin inhibitors 2fi3 
Crystal structure of a bpti variant (cys14->ser, cys38- >ser) in complex with trypsin 2fi4 
Crystal structure of a bpti variant (cys14->ser) in complex with trypsin 2fi5 
Crystal structure of a bpti variant (cys38->ser) in complex with trypsin 2fir 
Crystal structure of dfpr-viia/stf 2flb 
Discovery of a novel hydroxy pyrazole based factor ixa inhibitor 2flr 
Novel 5-azaindole factor viia inhibitors 2fmj 
220-loop mutant of streptomyces griseus trypsin 2fo9 
Structure of porcine pancreatic elastase in 95% acetone 2foa 
Structure of porcine pancreatic elastase in 40/50/10 % benzene 2fob 
Structure of porcine pancreatic elastase in 40/50/10 cyclohexane 2foc 
Structure of porcine pancreatic elastase in 55% dimethylformamide 2fod 
Structure of porcine pancreatic elastase in 80% ethanol 2foe 
Structure of porcine pancreatic elastase in 80% hexane 2fof 
Structure of porcine pancreatic elastase in 80% isopropanol 2fog 
Structure of porcine pancreatic elastase in 40% trifluoroethanol 2foh 
Structure of porcine pancreatic elastase in 40% trifluoroethanol 2fpz 
Human tryptase with 2-amino benzimidazole 2fs8 
Human beta-tryptase ii with inhibitor cra-29382 2fs9 
Human beta tryptase ii with inhibitor cra-28427 2ftl 
Crystal structure of trypsin complexed with bpti at 100k 2ftm 
Crystal structure of trypsin complexed with the bpti variant (tyr35->gly) 2fww 
Human beta-tryptase ii complexed with 4-piperidinebutyrate to make acylenzyme 2fx4 
Bovine trypsin bound by 4-piperidinebutyrate to make acylenzyme complex 2fx6 
Bovine trypsin complexed with 2-aminobenzamidazole 2fxr 
Human beta tryptase ii complexed with activated ketone inhibitor cra-29382 2fzz 
Factor xa in complex with the inhibitor 1-(3-amino-1,2- benzisoxazol-5-yl)-6-(2'-(((3r)-3-hydroxy-1-pyrrolidinyl) methyl)-4-biphenylyl)-3-(trifluoromethyl)-1,4,5,6- tetrahydro-7h-pyrazolo[3,4-c]pyridin-7-one 2g00 
Factor xa in complex with the inhibitor 3-(6-(2'- ((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3- (trifluoromethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4- c]pyridin-1-yl)benzamide 2g4t 
Anomalous substructure of porcine pancreatic elastase (na) 2g4u 
Anomalous substructure of porcine pancreatic elastaase (ca) 2g51 
Anomalous substructure of trypsin (p1) 2g52 
Anomalous substructure of trypsin (p21) 2g55 
Anomalous substructure of trypsin (p3121) 2g5n 
Indole-amidine complexes with bovine trypsin 2g5v 
Indole-amidine complexes with bovine trypsin 2g81 
Crystal structure of the bowman-birk inhibitor from vigna unguiculata seeds in complex with beta-trypsin at 1.55 angstrons resolution 2g8t 
Indole-amidine complexes with bovine trypsin 2gch 
Refined crystal structure of gamma-chymotrypsin at 1.9 angstroms resolution 2gct 
Structure of gamma-chymotrypsin in the range ph 2.0 to ph 10.5 suggests that gamma-chymotrypsin is a covalent acyl- enzyme adduct at low ph 2gd4 
Crystal structure of the antithrombin-s195a factor xa- pentasaccharide complex 2gdd 
Human beta ii tryptase with inhibitor cra-27592 2gde 
Thrombin in complex with inhibitor 2gkv 
Crystal structure of the sgpb:p14'-ala32 omtky3-del(1-5) complex 2gmt 
Three-dimensional structure of chymotrypsin inactivated with (2s) n-acetyl-l-alanyl-l-phenylalanyl-chloroethyl ketone: implications for the mechanism of inactivation of serine proteases by chloroketones 2gp9 
Crystal structure of the slow form of thrombin in a self- inhibited conformation 2gv6 
Crystal structure of matriptase with inhibitor cj-730 2gv7 
Structure of matriptase in complex with inhibitor cj-672 2h1u 
Porcine pancreatic elastase complexed with metpheleuglu at ph 5.0 2h9e 
Crystal structure of fxa/selectide/napc2 ternary complex 2h9t 
Crystal structure of human alpha-thrombin in complex with suramin 2hgt 
Structure of the hirugen and hirulog 1 complexes of alpha- thrombin 2hlc 
Hl collagenase structure at 1.7a resolution 2hnt 
Crystallographic structure of human gamma-thrombin 2hpp 
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin 2hpq 
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin 2hvx 
Discovery of potent, orally active, nonpeptide inhibitors of human mast cell chymase by using structure-based drug design 2hwl 
Crystal structure of thrombin in complex with fibrinogen gamma' peptide 2i6q 
Complement component c2a 2i6s 
Complement component c2a 2iln 
Crystal structure of the bowman-birk inhibitor from snail medic seeds in complex with bovine trypsin 2iot 
Clavulanic acid bound to elastase 2j2u 
Crystal structure of a human factor xa inhibitor complex 2j34 
Crystal structure of a human factor xa inhibitor complex 2j38 
Crystal structure of a human factor xa inhibitor complex 2j4i 
Crystal structure of a human factor xa inhibitor complex 2j94 
Crystal structure of a human factor xa inhibitor complex 2j95 
Crystal structure of a human factor xa inhibitor complex 2j9n 
Robotically harvested trypsin complexed with benzamidine containing polypeptide mediated crystal contacts 2jet 
Crystal structure of a trypsin-like mutant (s189d, a226g) chymotrypsin. 2jh0 
Human thrombin hirugen inhibitor complex. 2jh5 
Human thrombin hirugen inhibitor complex. 2jh6 
Human thrombin hirugen inhibitor complex. 2jkh 
Factor xa - cation inhibitor complex 2kai 
Refined 2.5 angstroms x-ray crystal structure of the complex formed by porcine kallikrein a and the bovine pancreatic trypsin inhibitor. crystallization, patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsin- pancreatic trypsin inhibitor complex 2nu0 
Molecular structures of the complexes of sgpb with omtky3 aromatic p1 variants trp18i, his18i, phe18i, and tyr18i 2nu1 
Molecular structures of the complexes of sgpb with omtky3 aromatic p1 variants trp18i, his18i, phe18i and tyr18i 2nu2 
Accommodation of positively-charged residues in a hydrophobic specificity pocket: crystal structures of sgpb in complex with omtky3 variants lys18i and arg18i 2nu3 
Accommodation of positively-charged residues in a hydrophobic specificity pocket: crystal structures of sgpb in complex with omtky3 variants lys18i and arg18i 2nu4 
Accommodation of positively-charged residues in a hydrophobic specificity pocket: crystal structures of sgpb in complex with omtky3 variants lys18i and arg18i 2nwn 
New pharmacophore for serine protease inhibition revealed by crystal structure of human urokinase-type plasminogen activator complexed with a cyclic peptidyl inhibitor, upain-1 2o8l 
Structure of v8 protease from staphylococcus aureus 2o8t 
Crystal structure and binding epitopes of urokinase-type plasminogen activator (c122a/n145q) in complex with inhibitors 2o8u 
Crystal structure and binding epitopes of urokinase-type plasminogen activator (c122a/n145q/s195a) in complex with inhibitors 2o8w 
Crystal structure and binding epitopes of urokinase-type plasminogen activator (c122a/n145q/s195a) in complex with inhibitors 2o9q 
The crystal structure of bovine trypsin complexed with a small inhibition peptide orb2k 2ocv 
Structural basis of na+ activation mimicry in murine thrombin 2od3 
Human thrombin chimera with human residues 184a, 186, 186a, 186b, 186c and 222 replaced by murine thrombin equivalents. 2odp 
Complement component c2a, the catalytic fragment of c3- and c5-convertase of human complement 2odq 
Complement component c2a, the catalytic fragment of c3- and c5-convertase of human complement 2ody 
Thrombin-bound boophilin displays a functional and accessible reactive-site loop 2ok5 
Human complement factor b 2olg 
Crystal structure of the serine protease domain of prophenoloxidase activating factor-i in a zymogen form 2oq5 
Crystal structure of desc1, a new member of the type ii transmembrane serine proteinases family 2oqu 
High pressure cryocooling of capillary sample cryoprotection and diffraction phasing at long wavelengths 2otv 
Crystal structure of the complex formed between bovine trypsin and nicotinamide at 1.56 a resolution 2oua 
Crystal structure of nocardiopsis protease (napase) 2oxs 
Crytal structure of the trypsin complex with benzamidine at high temperature (35 c) 2p16 
Factor xa in complex with the inhibitor apixaban (bms- 562247) aka 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1- piperidinyl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3, 4- c]pyridine-3-carboxamide 2p3f 
Crystal structure of the factor xa/nap5 complex 2p3t 
Crystal structure of human factor xa complexed with 3- chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2- carboxylic acid [4-chloro-2-(5-chloro-pyridin-2- ylcarbamoyl)-6-methoxy-phenyl]-amide 2p3u 
Crystal structure of human factor xa complexed with 3- chloro-n-(4-chloro-2-{[(5-chloropyridin-2-yl) amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1h-imidazol- 2-yl)methyl]thiophene-2-carboxamide {pfizer 320663} 2p8o 
Crystal structure of a benzohydroxamic acid/vanadate complex bound to chymotrypsin a 2p93 
Factor xa in complex with the inhibitor 5-chloro-n-(2-(4-(2- oxopyridin-1(2h)-yl)benzamido)ethyl)thiophene-2-carboxamide 2p94 
Factor xa in complex with the inhibitor 3-chloro-n-((1r,2s)- 2-(4-(2-oxopyridin-1(2h)-yl)benzamido)cyclohexyl)-1h- indole-6-carboxamide 2p95 
Factor xa in complex with the inhibitor 5-chloro-n-((1r,2s)- 2-(4-(2-oxopyridin-1(2h)-yl)benzamido) cyclopentyl) thiophene-2-carboxamide 2pgb 
Inhibitor-free human thrombin mutant c191a-c220a 2pgq 
Human thrombin mutant c191a-c220a in complex with the inhibitor ppack 2phb 
An orally efficacious factor xa inhibitor 2pka 
Refined 2 angstroms x-ray crystal structure of porcine pancreatic kallikrein a, a specific trypsin-like serine proteinase. crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin 2pks 
Thrombin in complex with inhibitor 2plx 
Trypsin complexed to a synthetic peptide from veronica hederifolia 2pr3 
Factor xa inhibitor 2psx 
Crystal structure of human kallikrein 5 in complex with leupeptin 2psy 
Crystal structure of human kallikrein 5 in complex with leupeptin and zinc 2ptc 
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors 2ptn 
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography 2puq 
Crystal structure of active site inhibited coagulation factor viia in complex with soluble tissue factor 2pux 
Crystal structure of murine thrombin in complex with the extracellular fragment of murine par3 2pv9 
Crystal structure of murine thrombin in complex with the extracellular fragment of murine par4 2pw8 
Crystal structure of sulfo-hirudin complexed to thrombin 2q1j 
The discovery of glycine and related amino acid-based factor xa inhibitors 2qa9 
Crystal structure of the second tetrahedral intermediates of sgpb at ph 4.2 2qaa 
Crystal structure of the second tetrahedral intermediates of sgpb at ph 7.3 2qn5 
Crystal structure and functional study of the bowman-birk inhibitor from rice bran in complex with bovine trypsin 2qxg 
Crystal structure of human kallikrein 7 in complex with ala- ala-phe-chloromethylketone 2qxh 
Crystal structure of human kallikrein 7 in complex with suc- ala-ala-pro-phe-chloromethylketone 2qxi 
High resolution structure of human kallikrein 7 in complex with suc-ala-ala-pro-phe-chloromethylketone 2qxj 
Crystal structure of human kallikrein 7 in complex with suc- ala-ala-pro-phe-chloromethylketone and copper 2qy0 
Active dimeric structure of the catalytic domain of c1r reveals enzyme-product like contacts 2qyi 
Crystal structure of a binary complex between an engineered trypsin inhibitor and bovine trypsin 2r0k 
Protease domain of hgfa with inhibitor fab58 2r0l 
Short form hgfa with inhibitory fab75 2r2m 
2-(2-chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors 2r2w 
Urokinase plasminogen activator b-chain-gppe complex 2r9p 
Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(bpti) 2ra0 
X-ray structure of fxa in complex with 7-fluoroindazole 2ra3 
Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti) 2rdl 
Hamster chymase 2 2rg3 
Covalent complex structure of elastase 2sfa 
Serine proteinase from streptomyces fradiae atcc 14544 2sga 
Electron density calculations as an extension of protein structure refinement. streptomyces griseus protease at 1.5 angstroms resolution 2sgd 
Asp 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 10.7 2sge 
Glu 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 10.7 2sgf 
Phe 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b 2sgp 
Pro 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 6.5 2sgq 
Gln 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 6.5 2sta 
Anionic salmon trypsin in complex with squash seed inhibitor (cucurbita maxima trypsin inhibitor i) 2stb 
Anionic salmon trypsin in complex with squash seed inhibitor (cucurbita pepo trypsin inhibitor ii) 2tbs 
Cold-adaption of enzymes: structural comparison between salmon and bovine trypsins 2tga 
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography 2tgd 
Lack of the transition state stabilization site is a factor in the inactivity of trypsinogen, a serine protease zymogen. structure of dfp inhibited bovine trypsinogen at 2.1 angstroms resolution 2tgp 
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors 2tgt 
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography 2thf 
Structure of human alpha-thrombin y225f mutant bound to d- phe-pro-arg-chloromethylketone 2tio 
Low packing density form of bovine beta-trypsin in cyclohexane 2tld 
Crystal structure of an engineered subtilisin inhibitor complexed with bovine trypsin 2tpi 
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography 2trm 
The three-dimensional structure of asn102 mutant of trypsin. role of asp102 in serine protease catalysis 2uuf 
Thrombin-hirugen binary complex at 1.26a resolution 2uuj 
Thrombin-hirugen-gw473178 ternary complex at 1.32a resolution 2uuk 
Thrombin-hirugen-gw420128 ternary complex at 1.39a resolution 2uuy 
Structure of a tick tryptase inhibitor in complex with bovine trypsin 2uwl 
Selective and dual action orally active inhibitors of thrombin and factor xa 2uwo 
Selective and dual action orally active inhibitors of thrombin and factor xa 2uwp 
Factor xa inhibitor complex 2v0b 
Sad structure solution porcine pancreatic elastase from a selenate derivative 2v35 
Porcine pancreatic elastase in complex with inhibitor jm54 2v3h 
Thrombin with 3-cycle no f 2v3o 
Thrombin with 3-cycle with f 2vgc 
Gamma-chymotrypsin d-para-chloro-1-acetamido boronic acid inhibitor complex 2vh0 
Structure and property based design of factor xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs 2vh6 
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with biaryl p4 motifs 2vid 
Serine protease splb from staphylococcus aureus at 1.8a resolution 2vin 
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator 2vio 
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator 2vip 
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator 2viq 
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator 2viv 
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator 2viw 
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator 2vnt 
Urokinase-type plasminogen activator inhibitor complex with a 1-(7-sulphoamidoisoquinolinyl)guanidine 2vu8 
Crystal structure of an insect inhibitor with a fungal trypsin 2vvc 
Aminopyrrolidine factor xa inhibitor 2vvu 
Aminopyrrolidine factor xa inhibitor 2vvv 
Aminopyrrolidine-related triazole factor xa inhibitor 2vwl 
Aminopyrrolidine factor xa inhibitor 2vwm 
Aminopyrrolidine factor xa inhibitor 2vwn 
Aminopyrrolidine factor xa inhibitor 2vwo 
Aminopyrrolidine factor xa inhibitor 2w26 
Factor xa in complex with bay59-7939 2w3i 
Crystal structure of fxa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 2w3k 
Crystal structure of fxa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 2win 
C3 convertase (c3bbb) stabilized by scin 2z7f 
Crystal structure of the complex of human neutrophil elastase with 1/2slpi 2za5 
Crystal structure of human tryptase with potent non-peptide inhibitor 2zc9 
Thrombin in complex with inhibitor 2zch 
Crystal structure of human prostate specific antigen complexed with an activating antibody 2zck 
Crystal structure of a ternary complex between psa, a substrat-acyl intermediate and an activating antibody 2zcl 
Crystal structure of human prostate specific antigen complexed with an activating antibody 2zda 
Exploring thrombin s1 pocket 2zdk 
Exploring trypsin s3 pocket 2zdl 
Exploring trypsin s3 pocket 2zdm 
Exploring trypsin s3 pocket 2zdn 
Exploring trypsin s3 pocket 2zdv 
Exploring thrombin s1 pocket 2zeb 
Potent, nonpeptide inhibitors of human mast cell tryptase 2zec 
Potent, nonpeptide inhibitors of human mast cell tryptase 2zf0 
Exploring thrombin s1 pocket 2zff 
Exploring thrombin s1-pocket 2zfp 
Thrombin inibition 2zfq 
Exploring thrombin s3 pocket 2zfr 
Exploring thrombin s3 pocket 2zfs 
Exploring trypsin s3 pocket 2zft 
Exploring trypsin s3 pocket 2zg0 
Exploring thrombin s3 pocket 2zgb 
Thrombin inhibition 2zgc 
Crystal structure of active human granzyme m 2zgh 
Crystal structure of active granzyme m bound to its product 2zgj 
Crystal structure of d86n-gzmm complexed with its optimal synthesized substrate 2zgx 
Thrombin inhibition 2zhd 
Exploring trypsin s3 pocket 2zhe 
Exploring thrombin s3 pocket 2zhf 
Exploring thrombin s3 pocket 2zhq 
Thrombin inhibition 2zhw 
Exploring thrombin s3 pocket 2zi2 
Thrombin inhibition 2ziq 
Thrombin inhibition 2zks 
Structural insights into the proteolytic machinery of apoptosis-inducing granzyme m 2znk 
Thrombin inhibition 2zo3 
Bisphenylic thrombin inhibitors 2zp0 
Human factor viia-tissue factor complexed with benzylsulfonamide-d-ile-gln-p-aminobenzamidine 2zpq 
Crystal structure of anionic trypsin isoform 1 from chum salmon 2zpr 
Crystal structure of anionic trypsin isoform 2 from chum salmon 2zps 
Crystal structure of anionic trypsin isoform 3 from chum salmon 2zq1 
Exploring trypsin s3 pocket 2zq2 
Exploring trypsin s3 pocket 2zwl 
Human factor viia-tissue factor complexed with highly selective peptide inhibitor 2zzu 
Human factor viia-tissue factor complexed with ethylsulfonamide-d-5-(3-carboxybenzyloxy)-trp-gln-p- aminobenzamidine 3b9f 
1.6 a structure of the pci-thrombin-heparin complex 3bef 
Crystal structure of thrombin bound to the extracellular fragment of par1 3bei 
Crystal structure of the slow form of thrombin in a self_inhibited conformation 3beu 
Na+-dependent allostery mediates coagulation factor protease active site selectivity 3bf6 
Thrombin:suramin complex 3bg4 
The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor 3bg8 
Crystal structure of factor xia in complex with clavatadine a 3biu 
Human thrombin-in complex with ub-thr10 3biv 
Human thrombin-in complex with ub-thr11 3bn9 
Crystal structure of mt-sp1 in complex with fab inhibitor e2 3bsq 
Crystal structure of human kallikrein 7 produced as a secretion protein in e.coli 3btd 
The crystal structures of the complexes between the bovine beta-trypsin and ten p1 variants of bpti. 3bte 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti. 3btf 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti. 3btg 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti 3bth 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti 3btk 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti 3btm 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti 3btq 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti 3btt 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti 3btw 
The crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti 3bv9 
Structure of thrombin bound to the inhibitor fm19 3c1k 
Crystal structure of thrombin in complex with inhibitor 15 3c27 
Cyanofluorophenylacetamides as orally efficacious thrombin inhibitors 3cen 
Factor xa in complex with the inhibitor n-(2-(((5-chloro-2- pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2h)- pyridinyl)benzamide 3cs7 
Factor xa in complex with the inhibitor 1-(4-methoxyphenyl)- 6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3- (trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin- 7(4h)-one 3d49 
Thrombin inhibition 3d65 
Crystal structure of textilinin-1, a kunitz-type serine protease inhibitor from the australian common brown snake venom, in complex with trypsin 3da9 
Crystal structure of thrombin in complex with inhibitor 3dd2 
Crystal structure of an rna aptamer bound to human thrombin 3dfj 
Crystal structure of human prostasin 3dfl 
Crystal structure of human prostasin complexed to 4- guanidinobenzoic acid 3dhk 
Bisphenylic thrombin inhibitors 3dt0 
Understanding thrombin inhibition 3dux 
Understanding thrombin inhibition 3e0n 
The x-ray structure of human prostasin in complex with dffr- chloromethyl ketone inhibitor 3e0p 
The x-ray structure of human prostasin in complex with a covalent benzoxazole inhibitor 3e16 
X-ray structure of human prostasin in complex with benzoxazole warhead peptidomimic, lysine in p3 3e1x 
The crystal structure of apo prostasin at 1.7 angstroms resolution 3e3t 
Structure of porcine pancreatic elastase with the magic triangle i3c 3e6p 
Crystal structure of human meizothrombin desf1 3e8l 
The crystal structure of the double-headed arrowhead protease inhibitor a in complex with two trypsins 3edx 
Crystal structure of the w215a/e217a mutant of murine thrombin 3ee0 
Crystal structure of the w215a/e217a mutant of human thrombin (space group p2(1)2(1)2(1)) 3egk 
Knoble inhibitor 3ela 
Crystal structure of active site inhibited coagulation factor viia mutant in complex with soluble tissue factor 3ens 
Crystal structure of human fxa in complex with methyl (2z)- 3-[(3-chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1- (2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate 3eq0 
Thrombin inhibitor 3est 
Structure of native porcine pancreatic elastase at 1.65 angstroms resolution 3f1s 
Crystal structure of protein z complexed with protein z- dependent inhibitor 3f68 
Thrombin inhibition 3f6u 
Crystal structure of human activated protein c (apc) complexed with ppack 3fp6 
Anionic trypsin in complex with bovine pancreatic trypsin inhibitor (bpti) determined to the 1.49 a resolution limit 3fp7 
Anionic trypsin variant s195a in complex with bovine pancreatic trypsin inhibitor (bpti) cleaved at the scissile bond (lys15-ala16) determined to the 1.46 a resolution limit 3fp8 
Anionic trypsin variant s195a in complex with bovine pancreatic trypsin inhibitor (bpti) determined to the 1.46 a resolution limit 3fvf 
The crystal structure of prostasin complexed with camostat at 1.6 angstroms resolution 3fzz 
Structure of grc 3g01 
Structure of grc mutant e192r/e193g 3gch 
Chemistry of caged enzymes. binding of photoreversible cinnamates to chymotrypsin 3gct 
Structure of gamma-*chymotrypsin in the range $p*h 2.0 to $p*h 10.5 suggests that gamma-chymotrypsin is a covalent acyl-enzyme adduct at low $p*h 3gic 
Structure of thrombin mutant delta(146-149e) in the free form 3gis 
Crystal structure of na-free thrombin in complex with thrombomodulin 3gov 
Crystal structure of the catalytic region of human masp-1 3gyl 
Structure of prostasin at 1.3 angstroms resolution in complex with a calcium ion. 3gym 
Structure of prostasin in complex with aprotinin 3h7o 
Crystal structure of scabies mite inactivated protease paralogue s-i1 (smipp-s-i1) 3h7t 
Crystal structure of scabies mite inactivated protease paralogue s-d1 (smipp-s-d1) 3hat 
Active site mimetic inhibition of thrombin 3hgn 
Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor fr130180 determined by neutron crystallography 3hgp 
Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor fr130180 determined by high resolution crystallography 3hk3 
Crystal structure of murine thrombin mutant w215a/e217a (one molecule in the asymmetric unit) 3hk6 
Crystal structure of murine thrombin mutant w215a/e217a (two molecules in the asymmetric unit) 3hki 
Crystal structure of murine thrombin mutant w215a/e217a in complex with the extracellular fragment of human par1 3hkj 
Crystal structure of human thrombin mutant w215a/e217a in complex with the extracellular fragment of human par1 3hpt 
Crystal structure of human fxa in complex with (s)-2-cyano- 1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2- (pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine 3hrz 
Cobra venom factor (cvf) in complex with human factor b 3hs0 
Cobra venom factor (cvf) in complex with human factor b 3htc 
The structure of a complex of recombinant hirudin and human alpha-thrombin 3ig6 
Low molecular weigth human urokinase type plasminogen activator 2-[6-(3'-aminomethyl-biphenyl-3-yloxy)-4-(3- dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2- yloxy]-4-dimethylamino-benzoic acid complex 3iti 
Structure of bovine trypsin with the mad triangle b3c 3jz1 
Crystal structure of human thrombin mutant n143p in e:na+ form 3jz2 
Crystal structure of human thrombin mutant n143p in e* form 3ptb 
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors 3ptn 
On the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography 3rp2 
The structure of rat mast cell protease ii at 1.9-angstroms resolution 3sga 
Structures of product and inhibitor complexes of streptomyces griseus protease a at 1.8 angstroms resolution. a model for serine protease catalysis 3sgb 
Structure of the complex of streptomyces griseus protease b and the third domain of the turkey ovomucoid inhibitor at 1.8 angstroms resolution 3sgq 
Gln 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 10.7 3tgi 
Wild-type rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti) 3tgj 
S195a trypsinogen complexed with bovine pancreatic trypsin inhibitor (bpti) 3tgk 
Trypsinogen mutant d194n and deletion of ile 16-val 17 complexed with bovine pancreatic trypsin inhibitor (bpti) 3tpi 
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors 3vgc 
Gamma-chymotrypsin l-naphthyl-1-acetamido boronic acid acid inhibitor complex 4cha 
Structure of alpha-*chymotrypsin refined at 1.68 angstroms resolution 4est 
Crystal structure of the covalent complex formed by a peptidyl alpha,alpha-difluoro-beta-keto amide with porcine pancreatic elastase at 1.78-angstroms resolution 4gch 
Structure and activity of two photoreversible cinnamates bound to chymotrypsin 4htc 
The refined structure of the hirudin-thrombin complex 4sga 
Structures of product and inhibitor complexes of streptomyces griseus protease a at 1.8 angstroms resolution. a model for serine protease catalysis 4sgb 
Structure of the complex of streptomyces griseus proteinase b and polypeptide chymotrypsin inhibitor-1 from russet burbank potato tubers at 2.1 angstroms resolution 4thn 
The crystal structure of alpha-thrombin-hirunorm iv complex reveals a novel specificity site recognition mode. 4tpi 
The refined 2.2-angstroms (0.22-nm) x-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the arg15 analogue of bovine pancreatic trypsin inhibitor 4vgc 
Gamma-chymotrypsin d-naphthyl-1-acetamido boronic acid inhibitor complex 5cha 
The refinement and the structure of the dimer of alpha- *chymotrypsin at 1.67-*angstroms resolution 5est 
Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate 5gch 
Chemistry of caged enzymes /ii$. photoactivation of inhibited chymotrypsin 5gds 
Hirunorms are true hirudin mimetics. the crystal structure of human alpha-thrombin:hirunorm v complex 5ptp 
Structure of hydrolase (serine proteinase) 5sga 
Structures of product and inhibitor complexes of streptomyces griseus protease a at 1.8 angstroms resolution. a model for serine protease catalysis 6cha 
Structure of a tetrahedral transition state complex of alpha-*chymotrypsin at 1.8-*angstroms resolution 6est 
Interaction of the peptide cf3-leu-ala-nh-c6h4-cf3(tfla) with porcine pancreatic elastase. x-ray studies at 1.8 angstroms 6gch 
Structure of chymotrypsin-*trifluoromethyl ketone inhibitor complexes. comparison of slowly and rapidly equilibrating inhibitors 7est 
Interaction of the peptide cf3-leu-ala-nh-c6h4-cf3(tfla) with porcine pancreatic elastase. x-ray studies at 1.8 angstroms 7gch 
Structure of chymotrypsin-*trifluoromethyl ketone inhibitor complexes. comparison of slowly and rapidly equilibrating inhibitors 7kme 
Crystal structure of human alpha-thrombin inhibited with sel2711. 8est 
Reaction of porcine pancreatic elastase with 7-substituted 3-alkoxy-4-chloroisocoumarins: design of potent inhibitors using the crystal structure of the complex formed with 4- chloro-3-ethoxy-7-guanidino-isocoumarin 8gch 
Gamma-chymotrypsin is a complex of alpha-chymotrypsin with its own autolysis products 8kme 
Crystal structure of human alpha-thrombin inhibited with sel2770. 9est 
Structural study of porcine pancreatic elastase complexed with 7-amino-3-(2-bromoethoxy)-4-chloroisocoumarin as a nonreactivatable doubly covalent enzyme-inhibitor complex - Links (links to other resources describing this domain)
-
INTERPRO IPR001254
